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2 ABBREVIATIONS 
 
AIDS      acquired immune deficiency syndrome 
BV                  bacterial vaginosis 
FTA-abs  fluorescent treponemal antibody absorption test  
HBC       hepatitis B virus  
HCV        hepatitis C virus  
HIV       human immunodeficiency virus 
HPV      human papilloma virus 
HSV      herpes simplex virus 
IUD          intrauterine device  
LCR        ligase chain reaction 
NGU     non-gonococcal urtehritis 
NIDR      National Infectious Diseases Register  
NPHI        National Public Health Institute  
PCR       polymerase chain reaction 
PID       pelvic inflammatory disease 
SSSC       sentinel STD surveillance clinic  
SSSN       sentinel STD surveillance network 
STD       sexually transmitted disease 
STI        sexually transmitted infection 
TPHA     treponema pallidum haemagglutination assay 
VDRL     venereal disease research laboratory test  
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3 SUMMARY 
 
Syphilis and gonorrhoea have been important sexually transmitted infections (STI) for 
centuries. During the past 20 years, Chlamydia trachomatis infection has been the most 
common bacterial STI in developed countries including Finland. The studies included in the 
present thesis were performed to investigate the epidemiology of syphilis, gonorrhoea, and 
C. trachomatis infection in the 1990s. 
 
In 1995, the incidence of syphilis doubled in Finland to 3.3/100 000 (population 5.1 million) 
and a local cluster of 18 cases was detected in the city of Tampere. The underlying reasons 
for this epidemic were analyzed and the occurrence of syphilis was monitored up to 2001 
using data from the cases notified to the National Infectious Disease Register (NIDR) (I).  
The main reasons for the increased incidence in 1995 and thereafter was the import of 
syphilis by Finnish heterosexual men from Russia where a significant epidemic was going 
on. The source partners were mostly sex workers, whereas mobile prostitution to Finland 
was not involved in the transmission. Most syphilis cases were found sporadically in 
southern Finland and secondary transmission was usually limited to one or two partners. The 
only isolated cluster developed in Tampere in 1995 due to unawareness of the risk of 
syphilis by the cases and local health care providers. From 1995 onwards, the incidence of 
syphilis remained at a constant level although travel to and from Russia more than tripled. It 
was concluded that general awareness by the public and health care providers about the risks 
of contracting syphilis abroad, and effective use of national surveillance and notification 
systems are needed to protect Finland from the spread of syphilis to an endemic infection.  
 
In 1990, Finland had a markedly higher incidence of gonorrhoea (55/100 000) than the other 
Nordic countries. A prospective study was performed in the two STD clinics in Helsinki in 
1990-1995 with special reference to endemic and imported sources of infection (II). 
Gonorrhoea decreased rapidly and in 1990-91 there were 490 patients (3.3% of all patient 
visits), in 1992-93 162 (1.3%) and in 1994-95 only 92 patients (0.9%). The change in the 
prevalence was highly significant (p<0.0001) and was entirely due to the decreased number 
of endemic infections. The rate of imported gonorrhoea remained constant although a severe 
epidemic was going on in neighbouring Russia and the Baltic countries. The prevalence of 
C. trachomatis infection decreased from 10.2% to 8.1% (p<0.001), but in contrast to 
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gonorrhoea the source of infection was mainly (89-97%) endemic. The patients with 
gonorrhoea were older and had a higher frequency of casual source partners than the patients 
with C. trachomatis infection, but these findings gave no obvious explanation for the rapid 
decline in endemic gonorrhoea.  
 
In the early 1990s the incidence of C. trachomatis infection was still high (150/100 000) in 
Finland and there was a need to obtain more detailed information on the incidence of new 
cases and on the presence of various risk factors. In the first study (III), data was collected 
using a self-administered questionnaire from 3 686 patients with and 32 230 patients 
without C. trachomatis infection visiting special sentinel STD surveillance clinics (SSSC) in 
1995-1997. The prevalence was 8.4% in the STD and 5.3% in the non-STD clinics, and 90% 
of the infections had an endemic source. The prevalence was highest in the youngest age 
group of 15-19 years (16% in women and 14% in men). The risk factors for C. trachomatis 
infection were a high number of sex partners, history of previous infection and in women 
also the use of oral contraceptives. Men contracted C. trachomatis infection frequently from 
a casual partner (61%) and women from a regular partner (61%). The median time from 
exposure to attendance was 5 weeks and prior to diagnosis one third of the patients could 
have spread the infection to a new partner. It was concluded that C. trachomatis infection is 
spread all over the country and that the risk factors are the same in Finland as those reported 
elsewhere, i.e. young age and high number of sex partners. Frequent transmission from 
regular partners, especially in women, should be taken into account in case finding and any 
effort to shorten the time from transmission to diagnosis would be an effective preventive 
strategy. 
 
In the second C. trachomatis study (IV) the incidence for all C. trachomatis cases (in the age 
group 10-69 years) notified by laboratories to the NIDR in Finland in 1995-2000 was 
calculated by gender for different age groups and domicile. The incidence increased from 
234/100 000 to 292/100 000 and the rise was most evident among people living in non-
urban densely-populated areas. The highest increase in incidence, 1.37 (95% confidence 
interval (CI) 1.29 to 1.46) -fold in women and 1.69 (CI 1.47 to 1.92) -fold in men, occurred 
in the youngest, 10-19-year-old, age group. In this age group the incidence of C. trachomatis 
infection was five times higher for women. The data from the sentinel STD surveillance 
network (SSSN) was analyzed for changes in risk-taking behaviour. In 2000, a significantly 
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higher percentage of women, but not men, in the age group 10-29 years reported 5 or more 
annual sex partners (18.8%; CI 16.3 to 21.6) than in 1995 (8.3%; CI 5.7 to 11.5). It was 
suggested that part of the increased incidence of C. trachomatis infection in Finland in 
1995-2000 could be due to the use of more sensitive laboratory methods. The observed high 
incidence and increasing number of annual sex partners in female adolescents and young 
adults show that this group could be a primary target for screening and educational 
programmes when trying to control the on-going epidemic of C. trachomatis infection in 
Finland. 
 
 
4 INTRODUCTION 
 
4.1 General introduction   
 
Sexually transmitted diseases have been an important health concern for mankind for a long 
time. Historically, syphilis has been the disease of fear by its potential for severe 
neurological and vascular sequelae and even death (Hook and Marra 1992). After the 
introduction of penicillin treatment the incidence of syphilis has fallen steadily over the past 
four decades throughout the developed world (Green et al. 2001). In contrast to Treponema 
pallidum, Neisseria gonorrhoeae has developed resistance to penicillin and finally, an 
outbreak of penicillinase-producing strains in the 1980s caused many problems in the 
control of gonorrhoea in Europe and elsewhere (Bignell 1996). 
 
In the late 1900s the spectrum of venereal diseases was widened considerably because of 
discoveries of new pathogens and increasing knowledge about the long-term sequelae of 
these infections. Chlamydia trachomatis was earlier known for causing the eye disease 
trachoma but it became evident that this intracellularly replicating bacterium was also a very 
important sexually transmitted pathogen. C. trachomatis was found to be a common cause 
of the so-called non-gonococcal urethritis (NGU) and also capable of causing pelvic 
inflammatory disease (PID) in women (Holmes et al. 1975, Mårdh et al. 1977, Ross 2002). 
The findings on the importance of sexually transmitted papilloma (HPV) and herpes simplex 
(HSV) virus infections as risk factors for cervical cancer were also of great importance (zur 
Hausen 1975, Lehtinen et al. 2001a ). The final change from the old venereal era of syphilis, 
  10 
chancroids and gonorrhoea was the outbreak of human immunodeficiency virus (HIV) 
infection in the United States and Europe in the 1980s followed by an epidemic in the 
developing world (Curran et al. 1985). The increasing number of pathogens and clinical 
outcomes pushed away the previous venereal era of curable bacterial diseases, i.e. syphilis, 
chancroids and gonorrhoea. At the same time the nomenclature has been changing. At 
present, the term sexually transmitted infections (STI) is preferred over the sexually 
transmitted diseases (STD), both by organizations such as World Health  Organization 
(WHO) and by various specialists and researchers working in the field. 
    
Today, STIs are recognized for the magnitude of illness they cause, the intensity of human 
suffering they generate and the amount of health resources they consume in the world. In 
spite of effective treatment, bacterial STIs are still a major public health concern in both 
industrialized and developing countries. WHO estimated that in 1990 there were 250 million 
new cases of bacterial STIs in the world and as many as 320 million cases in 1999, and it is 
of interest that C. trachomatis infection is more prevalent than gonorrhoea world-wide. The 
estimates for people with viral STIs are also huge, e.g. 34.3 million people infected with 
HIV in 1999.  
      
In Finland and the other Nordic countries syphilis, gonorrhoea and chancroid were common 
STIs in the 1930s. The incidence increased rapidly during the Second World War in 1939-
1944, but thereafter a significant decrease occurred due to the introduction of penicillin 
treatment (Moi 2001). In Finland, the government sought to combat venereal diseases by 
issuing the first Venereal Disease Act in 1939 and an amended version in 1952. Notification 
was mandatory and physicians were also advised to perform effective partner notification. 
Serological screening for syphilis was obligatory for sailors and prostitutes, and universal 
screening was also performed in the maternity clinics and by the blood transfusion services. 
In the 1970s, awareness of viral STIs, i.e. HSV and HPV infections, increased in Finland 
which was followed by important epidemiological and other research (Syrjänen K et al. 
1990, Lehtinen M et al. 2001b). After Chlamydia trachomatis was discovered to be the 
major causative agent of non-gonococcal urethritis and a risk pathogen for PID, active basic 
and clinical research has been performed in Finland by several groups (Saikku 2000). An 
important observation was that C. trachomatis infection could also trigger reactive arthritis 
(Keat 1983). In the new legislation on infectious diseases from 1987, C. trachomatis, but not 
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HPV or genital HSV infections, was classified as a notifiable infection and the same was 
true for HIV infection. The first cases of this severe infection in Finland were observed 
mainly among homosexual men (Valle 1987). Thereafter, heterosexual transmission has 
been increasing and in the late 1990s HIV infection started to spread among intravenous 
drug users. The incidence of HIV infection has, however, remained among the lowest in 
Europe (Leinikki 2002). 
      
In the early 1990s, the incidence of gonorrhoea was still markedly higher in Finland than in 
the other Nordic countries, whereas syphilis had been eradicated as an endemic disease 
(Moi, 2001). A syphilis and gonorrhoea epidemic in the neighbouring Russian Federation 
and the Baltic countries coinciding with an enormous increase in foreign travel was a new 
challenge for the control of syphilis and gonorrhoea in Finland (Tichonova et al. 1997). In 
addition, after a decline in the early 1990s the incidence of C. trachomatis infection started 
to increase. The purpose of this study was to get more detailed information on the 
epidemiology of gonorrhoea, syphilis and C. trachomatis infection in the 1990s in Finland. 
 
 
4.2 Sexually transmitted infections  
 
4.2.1 Syphilis and gonorrhoea  
 
Syphilis is a chronic disease caused by Treponema pallidum and can involve the skin, the 
central nervous system, the cardiovascular system, the skeleton and other organs. 
Treponema pallidum was demonstrated using dark-field microscopy in 1906. The first 
serological test for syphilis was described in 1906 by Wassermann. Salvarsan, the first 
effective drug against syphilis, was introduced in 1910 but after the discovery of penicillin 
in 1928 by Fleming and its large-scale production by Florey and Chain during the Second 
World War the management of syphilis advanced. Treponema pallidum  penetrates damaged 
skin and disseminates by the lymphatics and bloodstream. Transmission occurs in one third 
of patients exposed to early syphilis (Hook and Marra, 1992). The incubation period is 3-4 
weeks after which the primary chancre develops at the site of contact and is associated with 
regional adenopathy. During secondary syphilis a symmetrical rash, generalized 
lymphadenopathy and patchy hair loss can occur together with constitutional symptoms such 
as malaise, headache, low-grade fever or pain in the muscles. A patient with latent syphilis 
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is asymptomatic although the serological tests remain positive. Latent syphilis is divided 
into early (< 2 years) and late (>2 years) phases. Tertiary syphilis involves the cardiovascular 
and the central nervous systems (Hook and Marra 1992 ). Untreated syphilis during 
pregnancy can result in spontaneous abortion, stillbirth, intrauterine growth restriction, 
premature delivery, perinatal death and also serious sequelae in liveborn infected children 
(Genc and Ledger, 2000). The clinical spectrum of congenital syphilis encompasses 
manifestations ranging from laboratory or radiographic abnormalities in the otherwise 
normally appearing newborn to severe disease involving multiple organs (Genc and Ledger 
2000).    
 
Gonorrhoea is caused by Gram-negative cocci, Neisseria gonorrhoeae discovered by 
Neisser in 1879. The organism attacks mucous membranes, especially the columnar 
epithelium found in the urethra, the cervix uteri, rectum and conjunctivae. An intense 
inflammatory reaction follows with a massive polymorphonuclear response facilitating 
penetration of the mucosal lining by the N. gonorrhoeae. The incubation period is brief, 2-5 
days. In men the main symptom is a profuse purulent urethral discharge with dysuria; 
women are more often symptomless. Rare complications in men are epididymitis, prostatitis 
and urethral stricture. In women the most important complication, pelvic inflammatory 
disease (PID), is estimated to develop in less than 10% of untreated patients. Along with the 
declining incidence of gonorrhoea its importance as a cause of PID has diminished.   
 
 
4.2.2  C. trachomatis infection   
 
Non-gonococcal urethritis  was known as an infection of multiple aetiology. The principal 
cause was found to be C. trachomatis, which was isolated from 30-50% of men with NGU. 
The life cycle of C. trachomatis is slow and takes 24-36 hours. The infectious particles, 
elementary bodies (EBs), enter eukaryotic cells. They reorganise into a metabolically active 
form, reticulate bodies (RBs), which divide and differentiate to new EBs which are released 
and are capable of infecting other cells. Chlamydia trachomatis infection is considered to be 
the most prevalent bacterial STI in developed countries. C. trachomatis can cause urogenital 
infection, lymphogranuloma venereum and trachoma. The serovars L1, L2 and L3 cause 
lymphogranuloma venerum (LGV), an infection with genital ulcers mainly found in tropical 
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regions. Serovars A, B, Ba and C are found in trachoma, an infection of the eye which can 
lead to blindness. Infections in the urogenital tract are caused by serovars B, Ba, C and D-K. 
C. trachomatis was isolated in 1959 from the genital tract, a cell culture method for 
detection of C. trachomatis was established in 1965 and in the early 1970s the clinical 
manifestations of C. trachomatis were described. Clinical manifestations of urogenital 
infections include urtehritis, vaginal discharge, cervical bleeding and lower abdominal pain. 
However, a major part of the patients, especially women, seem to be clinically asyptomatic. 
In women infections may result in severe sequelae like PID, perihepatitis, infertility and 
ectopic pregnancies (Cohen and Brunham 1999, Ross 2002, Kamwendo et al. 2000, 
Paavonen and Eggert-Kruse 1999). Repeated C. trachomatis infections increase the risk for 
PID significantly (Hillis et al. 1997). Compared to women with only one reported C. 
trachomatis infection, those with three or more infections have a five- to six-fold increased 
probability of hospitalization for PID or ectopic pregnancy due to tubal damage (Hillis et al. 
1997)). C. trachomatis can trigger reactive arthritis (Keat 1983). Infants of mothers with C. 
trachomatis infection will develop conjunctivitis in 18-50% of cases and pneumonia in 11-
20% of cases.  
 
 
4.2.3 Other sexually transmitted infections 
 
An ulcerative STI, chancroid (ulcus molle), is caused by Haemophilus ducreyi. Chancroid 
was clinically differentiated from syphilis in 1852 and the causative organism was identified 
by Ducrey in 1889. In the tropics, chancroid is the predominant cause of genital ulceration. 
The incubation period is usually seven days after which an initial papule progresses to a 
pustule and ulcer with discharging inguinal bubo. The diagnosis is based on culture of the 
organism associated with a typical clinical picture.    
     
Herpes simplex virus type 2 (HSV2) and less frequently type 1 (HSV1) is the most common 
cause of genital ulcers in industrialized countries. HSV2 can cause recurrent vesicular and 
ulcerative lesions in the genital area. However, a significant proportion of individuals 
infected with HSV2 are asyptomatic. The clinical manifestations and recurrence rate are 
influenced by viral type and host factors. The diagnosis of genital herpes is often based on 
the clinical picture. HSV can be detected with culture, immunofluorescence (IF) or 
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polymerase chain reaction (PCR) from the lesion with a swab. Type-specific antibody 
testing allows the detection of asymptomatic or subclinical HSV2 carriers. Antiviral therapy 
(acyclovir, famcyclovir, valacyclovir) can be used for suppression of clinical manifestations 
but is not curative.             
     
Genital human papillomavirus (HPV) infection is the most common viral STI world-wide. 
Papillomaviruses were identified as viral particles by Strauss in 1949. In the early 1920s it 
was proposed that genital warts might be sexually transmitted. HPVs cause different clinical 
manifestations of which the most classical are genital warts easily diagnosed by the naked 
eye. However, most HPV infections are subclinical or latent. HPV types are divided into 
high and low risk types based on their oncogenic potential. There is a clear association 
between HPVs and cervical cancer (Lehtinen et al. 2001a.) HPV DNA testing can be used to 
detect the virus in the absence of disease. Genital warts are a challenge for management 
because of many recurrences. A wide range of therapies is available for the treatment of 
external genital warts (von Krogh et al. 2001). However, no therapy can eradicate the 
papillomaviruses and the recurrence rate including new lesions at previously treated or new 
remote sites is estimated to be 20-30% (von Krogh et al. 2001). The choice of therapy 
depends on the morphology and extent of the warts, the experience of the physician and the 
preferences of the patient. The management of genital warts can be divided into home and 
clinic therapy. Home therapy is considered the first-line therapy for the first attack of warts 
(von Krogh et al. 2001). Podofyllotoxin (0.5% solution and 0.15% cream) and imiqimod 
(5% cream) are self-applied by the patient; mild local skin reactions are a common side-
effect. Persistence or reappearance of the treated warts are indications for cryotherapy or 
surgical treatments such as carbon dioxide laser. Fortunately, HPV infection has a high 
spontaneous clearance rate.   
    
In 1981, a new STI, human immunodeficiency virus (HIV) infection was described first in 
the United States but today millions of people have been infected all over the world. In 
Finland the first acquired immune deficiency syndrome (AIDS) cases were diagnosed in 
1983 (Valle 1987). The clinical picture ranges from asyptomatic infection to manifest AIDS 
state and eventually to the death of the patient. During recent years early initiation of 
antiretroviral therapy has decreased the number of AIDS deaths. HIV infection is detected 
by testing for the anti-HIV antibodies. HIV is mainly transmitted sexually but transmission 
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by infectious blood or blood products has been documented. Indeed, vertical transmission 
from mother to child can occur in utero, at birth or via breast milk.  
     
Hepatitis B virus (HBV) is transmitted by sexual intercourse or by contact with infectious 
body fluids. HBV is present in the bloodstream, seminal fluid, saliva and breast milk. HBV 
can cause acute hepatitis with jaundice or asymptomatic infection. In 2-5% of adults and in a 
higher proportion of children the infection remains chronic, not infrequently causing 
cirrhosis and hepatocellular carcinoma. Hepatitis B is the only STI preventable by 
immunoprophylaxis. A safe and effective vaccine against hepatitis B is available. 
Vaccination of family members and regular sex partners of hepatitis B carriers is 
recommended to prevent infection. 
 
 
4.2.4 Trichomoniasis and related urogenital infections 
 
Trichomoniasis is the most common STI world-wide, especially in developing countries, but 
is now rare in Finland. Protozoan Trichomonas vaginalis was isolated in 1836 by Donne 
from a patient with vaginitis. The incubation period is 3-21 days. Transmission in adults is 
mainly by sexual contact, but the organism survives outside the body for 24 hours. Half of 
the women have symptoms, mainly florid vaginitis with profuse discharge. Men are 
commonly asymptomatic, but may have urethritis of short duration. Male carriage may 
commonly be transient (Krieger 1995). Trichomoniasis can be detected by culture of 
secretion from the vagina or urethra. Metronidazole is effective in the treatment of 
trichomoniasis, but resistant strains have been observed. 
 
The genital tract is the main site of colonization of mycoplasmas. Mycoplasma genitalium is 
an important pathogen in causing male urethritis and accounts for one third of non-
chlamydial, non-gonococcal urethritis (Uuskula and Kohl 2002). There is increasing 
evidence that M. genitalium can cause cervicitis (Uno et al. 1997) and endometritis (Cohen 
et al. 2002). However, the role of M. genitalium  as an agent of STIs is still controversial. 
PCR is a useful diagnostic method for detecting M. genitalium. Azitromycin is effective in 
the eradication of M. genitalium.  
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Bacterial vaginosis (BV) is a common cause of vaginal discharge with offensive smell and 
typical clinical presentation. BV is a change in vaginal ecology from the lactobacillary flora 
to a mixed microbial flora. BV is not included in the STIs, but can increase the rate of 
preterm deliveries or peripartum infections (Kekki et al. 2001). Metronidazole and 
clindamycin are the most effective treatment for BV (Paavonen et al. 2000). 
 
 
4.2.5 Diagnosis and treatment of syphilis, gonorrhoea and C. trachomatis infection  
 
In early syphilis mucocutaneous symptoms include primary sore and roseola rash. 
Treponema pallidum can be detected from the primary sore by dark-field examination, but 
the diagnosis must always be confirmed by serological tests (Wicher et al 1999). Non-
specific tests, such as the Venereal Disease Research Laboratory test (VDRL) and rapid 
plasma reagin test, are commonly used for screening. These tests turn positive 4-5 weeks 
after transmission and the Treponema pallidum haemagglutination (TPHA) test slightly 
later. The VDRL test is sensitive, but both transient and persistent false positive reactions 
may occur. Transient reactions can occur in infections and permanent false positive 
reactions, usually in low titers (<16), not infrequently occur in patients with autoimmune 
diseases (Wicher et al 1999). A Treponema pallidum immobilisation test was previously 
available in Finland for confirmation of the diagnosis of syphilis. At present, TPHA is 
widely used for this purpose. IgM antibodies can be measured with the fluorescent 
treponemal antibody absorption test (FTA-abs) and this test is useful particularly in the 
diagnosis of congenital syphilis (presence of IgM-class antibodies in cord blood).  
 
Penicillin has been and still is the drug of choice for the treatment of syphilis (Table 1). 
Procaine penicillin given daily as a single intramuscular injection of 600 000 units for two 
weeks in early and three weeks in latent syphilis has been the traditional treatment in 
Finland, in the other Nordic countries and elsewhere in Europe (Table 1). Recently, WHO 
recommended the use of a higher daily dose (1.2 mill. units) with the duration of treatment 
shortened to 10 days (WHO, 1999). In the United States, injection of long-acting penicillin 
bentzatine (2.4 mill. units) once or twice at an interval of one week has been preferred to 
procaine penicillin treatment due to compliance aspects (CDC, 1998). Oral doxycycline (200 
mg daily) was previously recommended as an alternative to penicillin but due to e.g. poorer 
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access to cerebrospinal fluid this drug is no longer in the same position in the treatment 
guidelines (CDC 1998, WHO 1999). When the patient with syphilis is allergic to penicillin, 
the alternative antibiotic is ceftriaxone (1 g daily intramuscularly). In early syphilis the first 
injection of penicillin often causes fever and a flare-up of the rash which is called 
Herxheimer´s reaction. The primary sore and lymphadenopathy heal rapidly during the 
penicillin treatment. The clinical response is followed by declining titers in VDRL and 
TPHA tests. These are routinely followed up for at least 12 months and a significant 
decrease in the titres or negative test results are considered as healing of syphilis.   
     
The diagnosis of gonorrhoea is based on positive culture of Neisseria gonorrhoeae. Swabs 
are taken from the uretra and cervix and when needed also from the rectum and pharynx. A 
new diagnostic possibility, available also in Finland from the year 2000, is the N. 
gonorrhoeae nuclear acid amplification test performed by the PCR technique in samples 
taken from the urine or cervix (Ching et al.1995, Van Dyck et al. 2001). The practical 
benefit of this test is that the same sample can be examined simultaneously for N. 
gonorrhoea and C. trachomatis. However, antibiotic sensitivity can be obtained only from 
specimens found positive in the culture. In the early 1980s in Finland, 10% of all imported 
N. gonorrhoea strains showed increased resistance to penicillin and one-quarter of the 
strains produced penicillinase (Pönkä et al. 1985). At the same time N. gonorrhoeae became 
increasingly resistant also to tetracyclines. Fluoroquinolones then came onto the market and 
these drugs were shown to be highly active against N. gonorrhoea. Since then, a single 500 
mg oral dose of ciprofloxacin has been the treatment of choice for gonorrhoea in Finland 
and elsewhere (Table 1, WHO 1999, CDC 1998). Recently, several reports, including one 
from Sweden and one from Finland, have focused attention on N. gonorrhoea strains which 
are resistant to ciprofloxacin and have been imported mainly from the Far East (Ross 1998, 
Berglund et al. 2002, Zenilman 2002, Huovinen et al. 2002). A recent report from the 
Finnish microbiological laboratories showed that over 10% of the N. gonorrhoea strains 
were resistant to ciprofloxacin (Huovinen et al. 2002). A single intramuscular injection of 
250 mg of ceftriaxone is used for the treatment of these resistant strains.  
      
Culture has been the gold standard for the detection of C. trachomatis from the 1970s  
(Black 1997). Specimens from the urethra and cervix are cultured in McCoy cell monolayers 
for two days. Elementary bodies in the infected cells are then shown by a fluorescent 
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antibody test using polyclonal or monoclonal reagents. Enzyme-linked immunoassays are 
based on the detection of chlamydial lipopolysaccharide by the antigen capture method, but 
a disadvantage of this method is cross-reactions with lipopolysaccharides from other gram-
negative bacteria. Therefore, the sensitivity and specificity of enzyme-linked immunoassays 
have been lower than that of C. trachomatis culture. In the early 1990s, sensitive and highly 
specific nucleic acid amplification tests were developed for the diagnosis of C. trachomatis 
infection (Loeffelholz et al. 1992). Nucleic acid amplification tests detect DNA or RNA and 
are not dependent on the viability of the organism. Non-invasive sampling also became 
possible because it was shown that these tests could detect C. trachomatis nucleid acid also 
from first-void urine in both men and women (Pasternack et al. 1996, Paukku et al. 1997). It 
also became evident that e.g. in the STD clinic setting these new tests based on polymerase 
or ligase chain reaction (LCR) detect more cases with C. trachomatis infection than the 
standard culture method (Puolakkainen et al. 1998). The specificity of the nucleic acid 
amplification tests was also good and in the late 1990s the majority of C. trachomatis 
infections were diagnosed with these new tests e.g. in Finland.    
    
Due to the slow life cycle of C. trachomatis, therapy should be based on antibiotics and 
treatment courses which give a high and long lasting concentration in the tissues where C. 
trachomatis replicates. This is true for tetracycline and doxycycline that have been used for 
the treatment of non-gonococcal urethritis and C. trachomatis infection for many years. 
Tetracycline 1.5 g or doxycycline 200 mg daily for a course of ten days eradicate C. 
trachomatis with low failure rates (Table 1). In the early 1990s, several comparative studies 
showed that in both men and women a single 1 g dose of azithromycin gives similar 
treatment results to a 7-day course of doxycycline (Lauharanta et al. 1993, Table 1). The 
cost of azithromycin treatment is higher than that of doxycycline or tetracyclines, but better 
compliance is a benefit (Lea and Lamb 1997). In contrast to N. gonorrhoea, C. trachomatis 
has not been found to have any significant antibiotic resistance in clinical conditions.  
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Table 1.  Management of syphilis, gonorrhoea and C. trachomatis infection in Finland  
 
 In the 1980s In the 1990s In 2002 
Syphilis Procaine penicillin  
600 000 units x 1 im. 2 weeks 
Procaine penicillin  
600 000 units x1 im.  
2 weeks  
Procaine penicillin 
1.2 million units x 1 im. 
10 days 
Gonorrhoea Procaine penicillin  
2.4 million units x 1 im. +  
Probenecid 1g x 1 po. 
Ciprofloxacine 
500 mg one oral dose 
Ciprofloxacine 
500 mg one oral dose or 
Keftriaxone 250 mg x 1 
im. 
C. trachomatis 
 infection 
Tetracycline 500 mg x 3  or 
Doxycycline 100 mg x 2  for   
10 days 
Azitromycin  
1 g one oral dose 
Azitromycin 
1 g one oral dose 
 
 
4.3 Surveillance of sexually transmitted infections in Finland 
 
National STD surveillance has a long tradition in Finland and the other Nordic countries 
(Moi 2001). Accordingly, the epidemiological behaviour of syphilis and gonorrhoea are well 
known from the Second World War. C. trachomatis and HIV infections have been followed 
carefully at the national level since 1987. Surveillance has been based on national legislation 
in which reporting is mandatory for all physicians, and from 1997 also for all laboratories. 
Legislation also covers patient care by providing STI patients with access to health care and 
treatment free of charge.  
 
 
4.3.1 Legislation  
 
The surveillance of syphilis, gonorrhoea, granuloma inguinale and ulcus molle was decreed 
in the Venereal Disease Act (”Lex veneris”) which was passed in 1939 and amended in 
1952 (Table 2). In addition to orders on treatment and reporting of infections, special 
attention was focussed on the contact tracing of source partners. A new Communicable 
Diseases Act and Decree in 1987 (issued in 1986) covered also STIs and classified syphilis 
as a disease dangerous to the community. In this context it has to be noted that, according to 
  20 
legislation, the term generally dangerous implies that the disease has to be dangerous and, in 
addition to that, society must have means to prevent the spread of the infection. Gonorrhoea, 
lymphogranuloma venerum, C. trachomatis, HIV and hepatitis B were listed as reportable 
infections, and the treatment of these diseases was free of charge for the patients. Genital 
HSV and HPV infections are not reportable infections, which means the patients have to pay 
for the drugs and other management themselves. 
 
The Ministry of Social Affairs and Health supervises and co-ordinates the control of STIs in 
Finland. Twenty-one hospital districts are responsible for the supervision of control in their 
areas. The system of local community health centres and their physicians are responsible for 
organising STD management and surveillance in their areas.       
 
Table 2. Legislation on sexually transmitted diseases in Finland 
        
“Lex veneris” 1952 Communicable Diseases Act 1987 
Reportable diseases Generally dangerous Reportable diseases Not reportable diseases 
 
Syphilis 
Gonorrhoea 
Granuloma inguinale 
LGV* 
Ulcus molle 
 
 
 
Syphilis 
 
Gonorrhoea 
Granuloma inguinale 
LGV* 
Ulcus molle 
C. trachomatis   
HIV infection 
HBV infection 
 
 Genital herpes 
 HPV infection 
*lymphogranuloma venerum 
 
 
 
4.3.2 Health care services   
 
General health care in Finland is based on public health centres serving the people living in 
a defined geographical area and general practitioners take care of patients with STIs along 
with other patients. Additional health centre services include antenatal clinics where about 
60 000 syphilis and HIV tests are performed yearly in the first trimester of pregnancy. In 
some cities there are special youth or family planning clinics which can perform STI testing 
whenever needed.  
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Most important for STI surveillance and care are the special STD out-patient clinics in the 
bigger cities. In 1995 there were two out-patient clinics in Helsinki and one in each in 
Turku, Tampere, Lahti, Kuopio and Oulu. These out-patient clinics have open access and 
the visits are free of charge for the patients. Whenever needed the STD patients can be taken 
to the wards in the university, central or district hospitals. Syphilis patients are routinely 
treated in the departments of dermatovenereology, HIV patients in internal medicine wards 
and patients with pelvic inflammatory disease in gynaecological wards. 
    
In addition to public health centres and hospitals there are special health services for 
university students and family planning clinics run by private foundations (Väestöliito, The 
Family Federation of Finland) in the biggest cities. There is also a notable private sector 
with offices for various specialists and occupational health care. The Finnish Red Cross 
Blood Transfusion Centre screens all blood used in Finland for syphilis and HIV infection. 
Anonymous HIV screening is available in the offices of the AIDS Council.                  
 
 
4.3.3 National Infectious Disease Register (NIDR)  
 
Since 1987, national surveillance of reportable STIs, i.e. syphilis, gonorrhoea, C. 
trachomatis  and HIV infection, has been based on the mandatory notification of cases by 
physicians to the NIDR in the National Public Health Institute. Only microbiologically 
confirmed cases of the above mentioned STIs are registered. Genital HSV and HPV 
infections are not reportable to the NIDR (Table 2). The register links all notifications by 
physicians to those from the laboratories as cases using the patient’s unique personal identity 
code. The information obtained from these notifications includes the age, gender, nationality 
and place of residence of the patient. The physician’s notification also includes information 
on source country and on partner notification actions.  
 
Since 1995, all laboratories have also been obliged to notify all reportable STIs diagnosed 
by them to the NIDR. Since 1997, C. trachomatis infections are sampled in the NIDR only 
from the laboratory notifications and physicians have been released from their duty to notify 
this infection.  
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The STD data registered in the NIDR is available in an aggregated format which is updated 
weekly for national and also for local hospital district or health care surveillance purposes. 
From 1998 the monthly reports have been available on the internet (www.ktl.fi).  
 
 
4.3.4 Sentinel STD surveillance network (SSSN) 
 
The national infectious disease surveillance system collects only a limited amount of 
information about the reportable STIs in the NIDR. Moreover, genital herpes simplex and 
human papillomavirus infections are not reported to the register. Consequently a sentinel 
STD network was established in 1995 (Hiltunen-Back et al. 1998). Initially this network 
consisted of six STD out-patient clinics, three health care centres, two university student 
health care units and two university hospital departments of gynaecology. In addition to 
patients with various STIs, data is also collected in the STD out-patient clinics from all 
attendees, i.e. also from those who did not have any STI. All attendees give detailed 
information on a questionnaire also about their previous risk taking behaviour, use of 
contraceptives, etc. Detailed partner information is also included from which the profiles of 
the source partners can be determined. 
 
 
4.4 Epidemiology of sexually transmitted infections   
 
4.4.1  Occurence in the world 
 
According to estimates of the WHO the annual number of new STIs world-wide is 
enormous (Table 3). In many countries there are surveillance systems for STIs but the data 
obtained is often incomplete. The statistical data on the incidence of STIs collected in the 
Nordic countries is considered to be the most reliable in the world (Moi 2001). In the Nordic 
countries systematic data on the incidence of STIs has been collected since the First World 
War. During wartime the incidence of syphilis and gonorrhoea increased and after the 
Second World War a rapid decrease occurred in all the Nordic countries. From the 1950s 
there was a continuous rise in the incidence of gonorrhoea and the highest figures were 
recorded in the 1970s. Thereafter the incidence of gonorrhoea decreased rapidly in Norway, 
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Sweden and Denmark. Syphilis was virtually eradicated in all Nordic countries after the 
Second World War, but all had epidemics in the 1970s among homosexual men. Recently 
there have been reports of new epidemics of syphilis among homosexual men in both 
Sweden and Norway (Moi 2001). Systematic data on the incidence of C. trachomtis 
infection has been available in all Nordic countries since the late 1980s. In the early 1990s 
there was a decline in the incidence of C. trachomatis infection but since 1994 an increase 
has occurred in all the countries (Moi 2001).  
 
In Russia the incidence of syphilis was very low in the 1960s, 2.5/100 000 in 1963 
(Tichonova et al. 1997). In the 1970s, an increase of cases occurred in Russia, but thereafter 
the incidence of syphilis declined continuously in the 1980s. In 1988 the incidence of 
syphilis was 4.3/100 000. Cases of gonorrhoea decreased similarly in the 1980s in Russia 
and in 1988 the incidence was 114/100 000.  
 
In Estonia the annual incidence of syphilis was constant (7/100 000) in 1959-1970 (Uuskula 
2001). An increase in the number of syphilis cases occurred in the 1970s with a peak in 
1976 (42/100 000), but thereafter the incidence declined in the 1980s. The incidence of 
gonorrhoea was constant in 1968-1981, with 250/100 000 cases annually. In the 1980s, a 
sharp decrease was observed. In Estonia, diagnostic methods for C. trachomatis were 
introduced in the early 1990s. According to a seroepidemiological study conducted among 
pregnant women in Tallinn, the prevalence of C. trachomatis  was 20.2%, HSV2 12.7% and 
HPV 36.1% (Kibur et al. 2000). Until 1999, 96 cases of HIV infections were reported. In 
2000, a huge increase occurred, especially among IV drug users, and altogether 390 cases 
were detected.           
 
Table 3. WHO* estimate of new cases of curable STIs in the world in 1999. 
 
 Syphilis Gonorrhoea C. trachomatis Trichomoniasis All 
World-wide 12 million 62 million 92 million 173 million 340 million 
West Europe 140 000 1 million 5 million 11 million 17 million 
North America 100 000 1.5 million 4 million 8 million 14 million 
*WHO, Global Prevalence and Incidence of Elected Curable Sexually Transmitted Diseases: 
Overview and Estimates. World Health Organization, Geneva (2001). 
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4.4.2  Occurence in Finland 
           
4.4.2.1 Syphilis and gonorrhoea before 1990   
 
Data on the incidence of gonorrhoea and syphilis has been collected since the 1930s in 
Finland. The incidence of syphilis was highest in 1943, when 5236 cases were reported 
(Härö 1996). In the 1940s, congenital syphilis was common with 50-80 cases annually (Härö 
1996). After maternity clinics were established in the 1950s in Finland, congenital syphilis 
decreased markedly. In the 1950s, syphilis was rare in Finland due to more effective 
penicillin treatment. The number of syphilis cases increased in the mid-1960s with a peak of 
300-400 cases annually (Aho and Lassus 1986). In the mid-1970s, a minor epidemic of 
syphilis occurred among homosexual men in Finland (Suhonen et al.1976 ). Since 1985, 
only 30-50 cases, mainly imported, have been reported annually.  
 
During the wartime in 1939-1944, gonorrhoea increased, reaching a peak incidence of 23 
566 reported cases in 1945 (Fig. 1) (Härö 1996). Thereafter there was a rapid decline mainly 
due to the introduction of penicillin for the treatment of gonorrhoea in 1948; in the 1950s 
the annual number of gonorrhoea cases was below 5000 (Härö 1996). In 1974 there was a 
new peak with 15 000 reported cases. After that there was a continuous decrease and in the 
early 1990s only 1000 gonorrhoea cases were detected annually. However, the decrease of 
gonorrhoea was even more rapid in the other Nordic countries.  
 
Figure 1. Number of gonorrhoea cases reported in Finland in 1935-1989. 
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4.4.2.2  C. trachomatis infection in 1987-1994 
 
C. trachomatis was later found to be the major causative agent in the previously common 
NGU. In the late 1970s, NGU was more common than gonorrhoea in STD clinics in 
Finland. In the United Kingdom, systematic data on the incidence of NGU has been 
collected since the 1950s and in 1982 the number of NGU cases was double the number of 
gonorrhoea cases (Morton 1987). In Finland, national incidence data on C. trachomatis 
infection has been collected since 1987. In 1987, 13 796 C. trachomatis cases were reported 
and the next year the number of cases exceeded 15 000. C. trachomatis infections have been 
mainly endemic and 5% of the cases have been imported. Unlike other STIs, 60-63% of 
cases are detected in women.  
          
 
4.4.2.3 Other sexually transmitted infections 
 
Ulcus molle, lymphogranuloma venerum and granuloma inguinale were quite common STIs 
in the 1930s. In 1935, 528 cases of ulcus molle, 144 cases of  granuloma inguinale and over 
100 cases of lymphogranuloma venerum were reported (Härö, 1996). Thereafter the 
incidence of these diseases decreased continuously. In the 1990s, only a few imported cases 
occurred in Finland.  
 
HIV infection has been reportable since 1987. The number of new cases was at a constant 
level, 50-70 reports annually, until 1999 (NPHI 2000). At the end of 1998 an epidemic of 
HIV infection occurred among intravenous (IV) drug users in southern Finland. 
Consequently, the number of new HIV cases increased in 1999 (143) and 2000 (145). The 
total number of HIV patients in Finland was 1 234 at the end of 2000 (NPHI 2001). The 
proportion of women with HIV infection increased in the 1990s and in 2000, 35% of new 
cases were detected in women. In 1990, 49% of HIV infections were acquired in 
homosexual contacts and 41% in heterosexual; in 2000 the percentages were 15% and 29%, 
respectively. Hepatitis B and C virus (HBV, HCV) infections are also mainly detected 
among intravenous drug users. HBV infection has been reportable since 1987 and HCV 
infection since 1995. During recent years the figures for hepatitis have been fairly constant 
with around 600 HBV cases and 1 700 HCV cases annually (NPHI 2000).   
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There is no national incidence data available on the non-reportable HPV and HSV 
infections. A seroepidemiological study among 16 733 pregnant women in Finland showed 
that the prevalence of HSV1 was 70% and HSV2 15.7% (Arvaja et al. 1999). In many sero-
epidemiological studies the prevalence of HSV2 infection has been 20-25% in the adult 
population. In the USA the prevalence of HSV2 has increased more than 30% over the last 
two decades and the increase has been greatest among white teenagers (Fleming 1997). The 
sentinel STD surveillance network has collected data on genital HSV infection in STD 
clinics since 1995. The prevalence of genital herpes has been fairly constant at 3.1-3.9%.  
 
There is no reliable test available for screening of anogenital HPV infections. The 
prevalence figures in different studies are dependent on the technique used to analyze the 
presence of HPV. The course of HPV infections is known to be fluctuating with multiple 
recurrences. Thus, the exact frequency of HPV infections cannot be estimated. The risk of 
infection varies with age, being highest in the age group 20-29 years. In an unselected 
Finnish female population at the age of 22 years, the annual incidence of HPV infections 
detectable by cytology was 7% in 1985-1986 (Syrjänen K et al. 1990). According to 
estimates of the life-time risk, up to 79% of Finnish women will contract at least one HPV 
infection between the age of 20 and 79 years (Syrjänen K and Syrjänen S 1990). In the 
sentinel STD surveillance clinics the prevalence of genital warts has been about 7.6%.    
 
 
4.5 Risk factors for sexually transmitted infections  
 
4.5.1 Travel 
 
Travel has had and still has an important role in the spread of STIs in the world. When 
armies moved during the First and Second World Wars, soldiers frequently contracted 
syphilis and gonorrhoea from prostitutes and the diseases were then carried with the soldiers 
to new areas. Sailors have also been an important group for the spread of STIs and earlier 
sailors often brought syphilis and chancroids to Finland. In the past two decades, truck 
drivers have been identified as an occupational risk group which easily contracts and 
transmits STIs. In the United States, counties along interstate highways have been shown to 
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be vulnerable to the spread of syphilis by truck drivers (Cook et al. 1999). In certain African 
countries the spread of the HIV epidemic can also be traced along the major highways 
(Mulhall 1996).  
     
Holiday travel has increased enormously in the world during recent years. Studies in genito-
urinary clinics in the United Kingdom have shown that unprotected sex with local people is 
not uncommon while on holiday abroad (Daniels et al.1992, Mendelsohn et al.1996). Sex 
tourism is linked with increased risks for the spread of STIs. In the 1970s, Finnish 
homosexual men were reported to have contracted syphilis when travelling abroad (Suhonen 
et al. 1976). In the 1990s, a few Finnish heterosexual men contracted HIV infection in 
Thailand where female sex workers have high infection rates (Mulhall 1996, NPHI 2000). 
Mobile prostitution across borders may have an increasing impact on the transmission of 
STIs. In agreement with this, sex workers from Eastern Europe were recently reported to 
have a high rate of syphilis (Smacchia et al. 1998).  
      
In Finland the pattern of imported STIs has been changing during the past few decades. In 
the 1960s, 6% of gonorrhoea cases were imported while in the early 1980s the percentage 
had increased to 11% and the source countries were mainly Russia, Spain and Thailand 
(Pönkä et al. 1985). Data on the source countries for C. trachomatis infection became 
available in the NIDR in 1987 when about 5% of the cases were contracted abroad. In the 
1980s, every second HIV patient contracted the infection abroad. In 1995-1999, only 24% of 
HIV infections in homosexual men were imported and the main source country was Spain 
(NPHI 2000). A different pattern existed in heterosexually acquired HIV infection, 65% of 
the cases in men and 30% in women were imported and in men the source country was 
mainly Thailand. It is of interest that 24% of all HIV infections notified in Finland in 1995-
1999 were in foreigners. 
 
 
4.5.2 Sexual behaviour  
 
The risk of acquiring STIs depends on the number of sexual partners, the extent of exposure 
and the prevalence of the infection in the partner population (Adler 1998). Young age has a 
major role in transmission of STIs because of high sexual partner change rates. Sex workers, 
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their clients, homosexual men and certain ethnic populations are also considered as groups 
of higher risk because of their sexual behaviour. Higher STI rates occur in urban areas where 
small sexually active core groups have been discovered to be an important source for 
maintaining gonorrhoea and C. trachomatis infection in certain populations (van de Laar 
1997).  
    
Safe sex and the use of condoms with casual partners are considered most important for the 
prevention of STIs (Adler 1998). Several studies have shown that consistent use of condoms 
correlates with decreased incidence of STIs (Evans et al.1995, Evans et al. 1997, Cates and 
Holmes 1996, Zenilman et al. 1995). Risk-taking behaviour is still common both in 
heterosexual and homosexual populations. Reports from the United Kingdom recently 
focused attention on the increasing rates of syphilis and HIV infection among homosexual 
men seemingly related to rare condom use during oral sex (Higgins et al. 2000). 
     
Sexual liberation and increasing use of oral contraceptives started in Finland in the 1960s. 
The number of partners in a life-time doubled and in the early 1990s every tenth Finnish 
woman reported having contracted a bacterial or viral STI (Kontula and Haavio-Mannila 
1993). Until 1971, homosexuality was considered a criminal offence in Finland. According 
to the information on men with syphilis in the STD clinics in Helsinki, 2% of patients had 
contracted the infection by a homosexual contact in 1964 while in 1975 the percentage had 
increased to 50% (Suhonen et al. 1976). In the beginning of the HIV epidemic in Finland in 
the 1980s, most cases were detected among homosexual men (Valle 1987). At present, 
transmission by homosexual contact is only 15%, whereas transmission by intravenous drug 
use has rapidly increased to 50% (NPHI 2000) 
 
 
4.6 Screening and prevention of sexually transmitted infections  
 
The control of STIs is based on promoting health-seeking behaviour and case finding among 
exposed individuals, treating those infected, notification of partners and finally prevention 
of infections by health education. Screening of asymptomatic infections caused by C. 
trachomatis  in various risk-groups by non-invasive sampling and testing with novel 
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laboratory techniques is a new possibility to reduce this important infection at the 
community level.  
 
4.6.1 Screening  
 
Screening of asymptomatic syphilis has a long tradition in health care. In Finland screening 
was arranged for prostitutes in 1944 and sailors were obliged to attend regularly for 
serological testing until the 1980s. Congenital syphilis can be prevented by antenatal 
screening of pregnant women. This has been widely adopted in many countries including 
Finland. Antenatal screening was established in the 1940s and the last case of congenital 
syphilis occurred in Finland in the 1980s. At present, all pregnant women are offered also 
testing for HIV and HBV infections and 99% participate (Koskela 2002). In the 1980s and 
thereafter, routine screening for syphilis, gonorrhoea, C. trachomatis and HIV infection has 
been conducted in the STD clinics. Women attending for termination of pregnancy have also 
been regularly screened for C. trachomatis infection. Recently, youth, family planning and 
student health clinics have been interested in screening for C. trachomatis infection but no 
organized screening has started yet.  
      
Reports from the Unites States and Sweden strongly suggest that effective screening for C. 
trachomatis infection in a given population decreases the rates of PID and tubal pregnancy 
(Scholes et al. 1996, Kamwendo et al. 1998, Egger et al. 1998). Therefore, screening for C. 
trachomatis has significant health benefits and is cost-beneficial even in a low prevalence 
population if the prevalence exceeds 3.9% (Paavonen et al. 1998). Several screening studies 
have now been performed to detect the prevalence of C. trachomatis infection in women in 
different clinical settings in Finland. The prevalence was 3.5% in the family planning clinic, 
3.9% in the adolescent health clinic and 2.5% in the antenatal clinic (Paukku et al. 1997). 
Among attendees in the STD clinics in Helsinki the prevalence of C. trachomatis infection 
was 6.3% in women and 8.9% in men in the mid-1990s (Puolakkainen et al. 1998).  
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4.6.2 Prevention  
 
Important strategies for the control of STIs include primary and secondary prevention 
measures (Adler 1998). The basis of primary prevention is health education to reduce the 
risk of contracting STIs. Education and promotion of condom use can have a significant 
impact on the disease uptake. In a study from Uganda consistent condom use significantly 
reduced the incidence of HIV infection, syphilis, gonorrhoea and C. trachomatis infection 
while irregular use was not protective against HIV or STI, but was associated with increased 
risk of gonorrhoea and C. trachomatis infection (Ahmed et al. 2001). A programme in Zaire 
succeeded in increasing condom use in high-risk groups such as sex workers and their 
clients (Laga et al. 1994). In parallel with increasing condom use, the incidence of STIs and 
particularly that of HIV infection declined. In Finland, after the emergence of HIV infection 
in the late 1980s, health education campaigns were established. These were supported by the 
mass media and included also annual mailing of a leaflet with a condom to every adolescent 
in the age group of 16 years. Adolescents also received sex education at school on 
contraception and STIs (Liinamo et al. 2000). The youth and family planning clinics provide 
contraceptive counselling but also promote sexual health with information about STIs.  
     
Secondary prevention of STIs includes case finding and management of the infection. In 
Finland, public health care and STD clinics offer free access to everyone, whether 
symptomatic or not, who wants a check-up for STIs. Treatment too is free of charge for 
patients who are infected with bacterial STIs or HIV. Partner notification is an important 
part of the secondary prevention of STIs. The optimal goal is to break the transmission chain 
(Clarke 1998). The patient can be encouraged to assume responsibility for locating and 
referring partners (Millson et al. 1994). In addition to partner referral, health care providers 
can actively participate in the process by interviewing the patient, locating the partners and 
assuring that the contacts are examined and treated. Data on the effectiveness of partner 
notification is rather scanty. A study performed in the United States reported that less than 
20% of the partners exposed to syphilis could be traced (Peterman et al. 1997). A study from 
Amsterdam showed that no more than 40% of the partners of patients with gonorrhoea and 
C. trachomatis infection could be traced (van de Laar et al. 1997). A study in Sweden 
showed that patients reported more partners to social workers than to physicians (Eitrem et 
al. 1998). A survey performed in Finland in 1995 showed that 67% of the patients with C. 
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trachomatis infection reported they were willing to inform their partners and 15% of the 
patients preferred this to be done by the health care provider (E. Hiltunen-Back, unpublished 
observation).  
 
Tertiary prevention includes effective treatment of STIs with antibiotics to eradicate the 
causative micro-organism in the host to interrupt transmission, to cure clinical 
manifestations and to prevent the development of serious sequelae 
. 
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5 AIMS OF THE STUDY  
 
The study was performed to elucidate the epidemiology of syphilis, gonorrhoea, and C. 
trachomatis infections in Finland in the 1990s. The goals of the four different studies 
performed were:  
 
1. Syphilis in Finland (I) 
This study analyzed the occurrence of syphilis in Finland in 1995-2000 with special 
reference to the consequences of imported cases due to the epidemic in Russia and the 
Baltic countries.  
 
2. Gonorrhoea in Finland (II) 
This study was performed in two STD clinics in Helsinki in 1990-1995 in order to 
discover the profiles of gonorrhoea patients and to examine whether the high incidence 
might be due to the importation of gonorrhoea.  
 
3. Survey of C. trachomatis infection in the sentinel STD surveillance network (III) 
The patient and control data from a special STD sentinel surveillance network in 1995-
1997 was analyzed in order to discover patient and partner profiles and to find out 
specific risk factors for C. trachomatis infection.  
 
4. Survey of C. trachomatis infection in Finland in 1995-2000 (IV) 
The laboratory notification data in the NIDR was analyzed for gender, age and domicile 
of the patients in order to discover the groups with the highest increase in incidence. 
Additional data from the SSSN was used to discover whether the observed increases in 
the incidence could be related to changes in risk-taking behaviour.  
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6 MATERIALS AND METHODS  
 
6.1 Study population   
 
The number of patients and controls, and source they were sampled from in the four studies 
is compiled in Table 4. 
 
 
 
 
Table 4. Source and number of patients examined in the present studies. 
_________________________________________________________________________ 
Study       Disease              Data source              Sample             No of patients  No of control 
patients           
I               Syphilis NIDR 1995 and 2000 276 
II             Gonorrhoea 2 STD clinics  1990-1995 744 836* 
III            C. trachomatis SSSC 1995-1997 3 689 32 230** 
IV            C. trachomatis NIDR, SSSC 1995-2000 61 845 
* case controls with C. trachomatis 
** patients without any STIs 
 
 
The information included in the C. trachomatis case notifications received by the NIDR 
from physicians and laboratories and the data sampled and analyzed from the patients with 
and without C. trachomatis in the SSSN is shown in Table 5. 
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Table 5. Epidemiological data collected and analyzed from patients with Chlamydia 
trachomatis in the three surveillance systems in Finland. (IV) 
 
 
 
 
 
 
Years in use  
 
Level 
 
Data collected 
 
Patient 
- age  
- gender 
- nationality 
- place of residence 
- previous STIs* 
- number of partners* 
- contraception use 
Infection 
-source place 
-date 
-source partner  
-other partners 
Name of reporting 
clinic or laboratory 
Laboratory method 
used  
 
  Physician’s    
  Notification 
     
  1987-1997 
 
   nationwide 
 
 
 
 
         + 
         + 
         + 
         + 
          - 
          - 
          - 
 
         + 
         + 
          - 
          - 
 
         + 
 
         -                  
   Laboratory    
   Notification 
 
    from 1995 
 
   nationwide 
 
 
 
 
          + 
          + 
           - 
           - 
           - 
           - 
           - 
 
           - 
           - 
           - 
           - 
 
           + 
 
           + 
Sentinel STD surveillance  
        Network 
  
      from 1995 
 
7 STD and 5 health-       
      care clinics 
 
 
 
               + 
               + 
               + 
               + 
               + 
               + 
               + 
 
               + 
               + 
               + 
               + 
 
               + 
 
               + 
 
 
STI = sexually transmitted infection 
STD = sexually transmitted disease 
*during preceding 12 months 
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6.1.1 Patients with syphilis (I) 
 
Data from all patients with syphilis reported to the NIDR by physicians in Finland in 1995 
and 2000 was analyzed. The register included 120 patients with syphilis in 1995 and 156 
patients in 2000. The notification forms sent by physicians to the NIDR include age, gender 
and nationality of the patient, place of residence and source of infection. International 
diagnosis codes (ICD-10) were used for the staging of syphilis. The syphilis cases reported 
to the NIDR in 1995 were analyzed more thoroughly by sending a specific questionnaire to 
all physicians who had notified one or more syphilis cases. They were asked whether the 
source of infection in Finland or abroad they had reported to the NIDR was based on reliable 
information. Moreover, additional data was collected on source partners (e.g. sex workers) 
and modes of transmission.  
     
The patients with syphilis found by screening in the STD clinics, and among blood donors 
and pregnant women in Finland in 1995 and 2000 were analyzed. A local syphilis cluster 
occurring in Tampere in 1995 was examined in more detail, with special attention to source 
partners and modes of transmission.  
 
 
6.1.2 Patients with gonorrhoea and case controls with C. trachomatis infection (II) 
 
The records from all gonorrhoea patients attending the two STD clinics in Helsinki during 
three different 12-month periods in 1990-1995 were analyzed. The number of patients with 
gonorrhoea was 490 in 1990-1991, 162 in 1992-1993 and 92 in 1994-1995. Data sampled 
from the patient records included gender and age, nationality, profession, marital status and 
source of infection.    
   
Control patients for each patient with gonorrhoea included the next patient with C. 
trachomatis infection (two in the last series) matched by gender. The total number of case 
controls with C. trachomatis infection was 836 and their patient records were analyzed 
similarly to those for patients with gonorrhoea.        
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The incidences of gonorrhoea and C. trachomatis infection in Finland in 1990-1995 were 
from the NIDR. The gonorrhoea incidences in St. Petersburg, Russia, Estonia and Sweden 
were obtained from the national registries of the respective countries.  
 
 
6.1.3 Patients with and without C. trachomatis infection in the SSSN survey (III)  
 
All 3 689 patients with  C. trachomatis infection diagnosed in the sentinel STD surveillance 
network clinics in 1995-1997 were analyzed (Table 6). All 32 230 patients who visited the 
STD out-patient network clinics in the same period but who did not have C. trachomatis or 
other STIs were included as a control group for the patients with C. trachomatis.  
 
In 1995, the sentinel STD network clinics consisted of four STD out-patient clinics in 
Helsinki, Tampere, Turku and Oulu, three primary health care centres in Lappeenranta, 
Kauhajoki and Ivalo and two student health care clinics as well as two university hospital 
gynaecological clinics in Helsinki and Oulu (III, Fig. 1). In 1996 –1997, three more STD 
clinics, one in Helsinki, one in Tampere and one in Kuopio, joined the network. In 1999, the 
STD network clinic in Oulu was closed. The STD network clinics collect data from all 
attendees while the non-STD clinics collect data only from those patients who have been 
diagnosed as having syphilis, gonorrhoea, C. trachomatis or HIV infection. The data is 
collected using a self-administered, 21-point questionnaire that patients fill in before 
attending the physician in the STD clinics or after the diagnosis in the non-STD clinics. 
Besides normal demographic data, information was collected on symptoms, contraceptives, 
previous STIs, partner notification, source of infection and transmission onwards.     
     
The data from questionnaires is entered in a computer by every clinic using specific in-house 
software. Every network clinic can get up-dated reports from the data on STI incidence and 
demographic profiles of the patients. In addition, anonymous data from the patients in the 
various STD network clinics is compiled annually by the National Public Health Institute.     
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Table 6. Number of patients tested for C. trachomatis and number of positive findings in 
STD and non-STD clinics in 1995-1997 (III) and in 1995-2000 (IV). 
 
 STD clinics Non-STD clinics 
 All tested Chlamydia 
patients 
 
All tested Chlamydia 
patients 
Year N N (%) N N (%) 
1995 7 939 732 (9.2) 5 490 327 (6.0) 
1996 9 696 738 (7.5) 6 049 334 (5.6) 
1997 14 595 1 222 (8.4) 7 207 336 (4.7) 
1998 19 919 1 518 (7.6) 10 155 357 (3.5) 
1999 20 208 1 644 (8.1) 9 194 285 (3.1) 
2000 22 435 1 845 (8.2) 10 500 358 (3.4) 
 
 
6.1.4 Patients with C. trachomatis infection in the NIDR survey (IV) 
 
All physicians’ and laboratory notifications of C. trachomatis infection sent to the NIDR in 
1995 were analyzed in order to determine the coverage of notifications from these two 
sources. Thereafter, all C. trachomatis cases reported by laboratories in 1995-2000 were 
analyzed according to age, gender and domicile. Altogether 61 845 C. trachomatis 
infections were registered in the age group of 10-69 years. The comparison was made 
between incidence and other data in 1995-2000 in the male and female cohorts with the 
highest C. trachomatis infection rates. The annual figures for women and men in the 10-year 
age groups and population data   were acquired from Statistics Finland. In urban areas 
>90%, in densely populated areas 60-90% and in rural areas <60% of the population were 
living in the population centres. The data on risk behaviour of patients with C. trachomatis 
infection was collected from the sentinel STD network data and analyzed separately for men 
and women (Table 6).   
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6.2 Diagnosis of syphilis, gonorrhoea and C. trachomatis infection  
 
In Study I, serological screening of syphilis cases was performed with the Venereal Diseases 
Research Laboratory (VDRL) test, commonly known as the Cardiolipin test in Finland. All 
positive test results were confirmed by TPHA and a titre over 80 was considered diagnostic 
for syphilis. 
    
In Study II, diagnosis of gonorrhoea was based on positive culture of Neisseria 
gonorrhoeae. Swabs were taken from the urethra in men and cervix in women in a transport 
medium (Stuart, Amies) and then cultured in a Thayer-Martin medium in bacteriological 
laboratories serving the two STD out-patient clinics.  
     
In Study II, C. trachomatis samples were taken with cotton swabs from the urethra in men 
and from the cervix in women and put in tubes containing a transport medium (2-SP). 
Thereafter, samples were cultured for 48 hours in McCoy cells in microbiological 
laboratories and chlamydia antigen was detected with a commercial culture confirmation 
reagent (MicroTrak) as previously described (Puolakkainen et al.1998). 
     
In the sentinel surveillance study (Study III) in 1995 the same C. trachomatis culture method 
or commercial immunoassay tests were used in laboratories that served the STD network 
clinics. Beginning in 1996, first-void urine samples in men and cervical swab samples in 
women were examined with polymerase or ligase chain reaction (PCR/LCR) as previously 
described (Puolakkainen et al. 1998). In 1997, the percentage usage of these new test 
methods was 63% in the STD and 71% in the non-STD clinics. In Study IV, covering all C. 
trachomatis infections notified by the laboratories in Finland, 63% of patients with C. 
trachomatis were diagnosed by antigen detection tests, 16% by culture and 21% by 
PCR/LCR tests in 1995. In 2000, 95% of the patients with C. trachomatis were diagnosed 
by PCR/LCR tests.   
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6. 3 Biostatistics  
 
In Study II, the prevalence (period prevalence) of gonorrhoea and C. trachomatis infection 
with 95% confidence limits in each of the three series, i.e. in 1990-1991, 1992-1993 and 
1994-1995, was calculated from the total number of attendees visiting the two STD clinics 
in Helsinki. The change in the prevalence was analyzed with the Chi-square test for linear 
trend. The same tests were used to analyze the changes in the number of patients with 
gonorrhoea and C. trachomatis infection with endemic source of infection. Student’s t-test 
was used to test concomitant occurrence of gonorrhoea and C. trachomatis infection in the 
patients with endemic and imported gonorrhoea. Student’s t-test with a separate variance 
estimate was used to analyze demographic findings in the patients with gonorrhoea and case 
controls with C. trachomatis infection. A p-value less than 0.05 was considered significant.   
     
In Study III, data from the patients with C. trachomatis infection and from the controls 
without STIs collected in the 12 STD sentinel surveillance network clinics in 1995-1997 
was analyzed. Comparisons were made between the data from the STD and non-STD 
clinics. The risk factor analyses were performed and expressed from data sampled from the 
whole three-year period since annual analyses in the first and last year of the study gave the 
same risk factor results. Variables with normal distribution descriptive values were 
expressed by mean and standard deviations (SD); statistical comparison between the groups 
was performed by t-test, z-test or analysis of variance (ANOVA). Variables with ordinal 
descriptive values were expressed as medians and interquartile ranges (IQR); comparisons 
between the groups were performed with the Mann-Whitney test or Kruskal-Wallis test. 
Measures with a discrete distribution were expressed as counts (%) and analyzed by Chi-
square. No adjustment was made for multiple testing. 
 
In Study IV, 95% yearly incidence rates of C. trachomatis infection/10 000 were calculated 
with MID-P 95% CI. Direct age standardization to compare the annual change in incidence 
and incidence ratio of urban and rural populations were calculated by Poisson regression 
models. 
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7 RESULTS  
 
7.1 Syphilis in Finland in 1995-2000 (I)   
 
7.1.1 Outbreak of syphilis in 1995 
 
The incidence of syphilis reported to the NIDR showed a sharp increase in 1995 (I, Fig. 1). 
The number of cases doubled from 1994 and in 1995 the incidence was 3.3/100 000 (I; 
Table 1). Most of the syphilis cases were detected near the eastern border or in the Helsinki 
metropolitan area on the southern coast of Finland, but an isolated local cluster of 18 cases 
occurred in the City of Tampere in southern Finland (I, Fig.2). 
    
Most patients with syphilis (83%) were Finnish citizens and 63% were men (I, Table 2). Of 
the 120 patients, 78% had primary or secondary and 12% had early latent syphilis. Overall, 
60% of the patients were diagnosed due to symptoms, 27% were detected by partner 
notification and were generally asypmtomatic, and 13% were asymptomatic cases found by 
serological screening among pregnant women and blood donors (I, Table 4). 
    
Half of the syphilis cases in 1995 were contracted abroad, mostly in Russia and also a few 
cases in Estonia and Thailand (I, Table 2). The source partners for men were frequently sex 
workers or other casuals (I, Table 3). Women contracted syphilis mostly in Finland from 
casual or regular source partners. 
 
 
7.1.2 Syphilis in 1995-2000  
 
After the syphilis outbreak in Finland in 1995, the number of syphilis cases reported to the 
NIDR remained fairly constant (I; Fig.1) although travel between Finland and Russia or 
Finland and Estonia increased markedly. In 2000, physicians notified a total of 156 syphilis 
cases mainly in eastern and southern Finland. The source in men was still mainly Russia and 
in women Finland (I, Table 2). 
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In contrast to the fairly constant level of syphilis cases reported to the NIDR, the prevalence 
of syphilis among attendees at the STD surveillance network clinics decreased from 4.5% in 
1995 to 2.4% in 2000 (I, Table 4). Antenatal screening disclosed six pregnant women with 
syphilis in 1995 and nine cases in 2000. One case of congenital syphilis was detected in 
2000.  
 
 
7.2 Gonorrhoea in Helsinki in 1990-1995 (II)  
 
7.2.1 Prevalence and incidence  
 
In the two STD out-patient clinics in Helsinki the number of gonorrhoea patients decreased 
during the study from 490 in 1990-1991 to 161 in 1992-1993, and then to 92 in 1994-1995 
(Table 7). The prevalence of gonorrhoea among attendees was 3.3%, 1.3% and 0.9%, 
respectively, which was a highly significant decrease (p< 0.0001). In the same period the 
incidence of gonorrhoea reported to the NIDR in Finland decreased from 47/ 100 000 to 
7/100 000 and has remained at a constant level thereafter (Fig. 2). During the study the 
prevalence of C. trachomatis infection decreased in the two STD clinics from 10.2% to 
8.1%  (p<0.001; Table 6) and the incidence in Finland decreased from 251/100 000 to 
182/100 000 (Fig. 3).  
 
Figure 2. Incidence (/100 000 ) of gonorrhoea during the study period 1990-1995 (II) and 
thereafter in Finland (NIDR). 
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Figure 3. Incidence (/100 000 ) of C .trachomatis infection in Finland in 1990-2000 
(National Infectious Disease Register).  
  
  
 
 
Table 7. Number of patients with gonorrhoea contracted in Finland and abroad in the two 
STD clinics in Helsinki during the three different study periods in 1991-1995. Case controls 
with C. trachomatis infection are also presented (II).                                                     
                      
Study period 1990-1991 1992-1993 1994-1995 
No of attendees 14 778 12 887 10 600 
Patients with 
gonorrhoea 
   
 
490 (3.3.%) 
 
162 (1.3%) 
 
92 (0.9%) 
Contracted in Finland 427 (87%) 108 (67%) 42 (46%) 
Contracted abroad 63 (13%) 54 (33%) 50 (54%) 
Patients with  
C. trachomatis          
 
1 500 (10.2%) 
 
 
1 095 (8.5%)  
 
 
855 (8.1%) 
 
Case controls with  
C. trachomatis  
490 162 184 
Contracted in Finland 435 (89%) 156 (96%) 178 (97%) 
Contracted abroad 55 (11%) 6 (4%) 6 (3%) 
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7.2.2 Endemic and imported gonorrhoea 
 
The decreased prevalence of gonorrhoea among attendees at the STD clinics was due to a 
decreased number of patients with an endemic source of infection (Table 7). During the 
study the frequency of patients who contracted gonorrhoea in Finland decreased from 87% 
to 46% which is a significant (p<0.0001) decrease (Table 7). The number of patients with 
imported gonorrhoea remained constant (i.e. 63, 54 and 50 patients) during the study. Of the 
patients with gonorrhoea contracted abroad, 37% in 1990-1991, 72% in 1992-1993 and 88% 
in 1994-1995 were infected in Russia or Estonia. 
     
The frequency of imported C. trachomatis infection decreased among the control cases from 
11% in 1990-1991 to 3% in 1994-1995 which is a significant (p<0.001) decrease (Table 7). 
The frequency of a concomitant C. trachomatis infection was 31% in the patients with 
endemic gonorrhoea and 14% in the patients with imported gonorrhoea.  
 
 
7.2.3 Demographic findings and source partners 
 
In the three series most, i.e. from 68% to 78%, of the patients with gonorrhoea were men (II, 
Table 3). The mean age was from 30 to 32 years in men and from 25 to 28 years in women. 
The mean age of the control cases with C. trachomatis infection was significantly lower 
(p<0.001), from 27 to 28 years in men and from 23 to 24 years in women.  
     
The patients with gonorrhoea had casual source partners significantly (p<0.001) more often 
than the controls with C. trachomatis infection (II, Table 4). In the time periods the 
frequencies of casual source partners varied in men with gonorrhoea from 82% to 93% and 
in women from 53% to 60%. The corresponding frequencies varied in the men with C. 
trachomatis infection from 68% to 78% and in women from 17% to 41 %.   
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7.3 C. trachomatis infection in the SSSN in 1995-1997 (III) 
 
7.3.1  Prevalence   
 
During the three-year study period a total of 3 689 patients with C. trachomatis infection 
were registered in the sentinel STD surveillance network. Of these patients, 2 692 were 
detected in the STD clinics and 997 in the non-STD clinics (III, Table 2). In the STD clinics 
the overall detection rate of C. trachomatis infection was 8.4% (8.8% in men and 7.8% in 
women) and remained stable during the three-year study period. The detection rate was 
highest, 14.3% in men and 15.9% in women, in the age group 15-19 years (III, Fig. 2). In the 
non-STD clinics the overall detection rate of C. trachomatis infection was 5.3% and it 
decreased from 6% in 1995 to 4.7% in 1997. 
 
 
7.3.2 Gender and age of the patients  
 
Patients with C. trachomatis were more often (61%) men in the STD clinics, whereas 
women (62%) outnumbered men in the non-STD clinics (III, Table 3). The mean ages of the 
men with C. trachomatis (26.6 years and 26.2 years, respectively) were significantly higher 
than the mean ages of the women (23.7 years and 24.4 years, respectively). 
     
The patients with C. trachomatis infection in the STD clinics were compared with the 
attendees without C. trachomatis infection (Table 8). The mean age of patients with C. 
trachomatis infection (26.6 years in men and 23.7 years in women) was significantly lower 
than the mean age of patients without C. trachomatis infection (31.7 years in men and 28.4 
years in women). 
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Table 8 . Demography, source partners and risk behaviour in the patients with and without 
C. trachomatis infection in the STD clinics in 1995-1997 (III). 
              
 Men Ct+* Men Ct- Women Ct+ Women Ct- 
Number of patients 1 633 14 205 1 057 11 475 
Mean age (years) 26.6 31.7 23.7 28.4 
Contraception method      
None NE** NE 32.9% 43.9% 
Condom NE NE 7.9% 14.2% 
Oral contraceptives NE NE 55.2% 34.1% 
IUD***or other NE NE 3.8% 7.8% 
Source partners     
Regular 36.8% 35.4% 60.6% 54.5% 
Casual 60.9% 57.5% 39.4% 45.5% 
Met abroad 6.9 % 13.6% 4.9% 7.8% 
Risk taking behaviour 
>5 partners/12 months 
 
32% 
 
17.6% 
 
14.2% 
 
9.8% 
Previous Ct+/12 months 9.9% 5.1% 11.1% 7.5% 
* Ct= C. trachomatis infection 
**NE== not evaluable 
***IUD = intrauterine device 
 
 
7.3.3 Source partners and source countries 
 
Men contracted C. trachomatis infection mostly (61%) from a casual partner while for 
women a regular partner was the most common (61%) source (Table 8). Only 2% of the men 
with a C. trachomatis  infection reported a sex worker as a source partner compared to 7% 
in the non-infected men.  
    
When the time between exposure and diagnosis of C. trachomatis was analyzed, the median 
time to attendance at the STD clinic was 31 days in men and 37 days in women (III, Table 
6). The time to attendance was highest (46 days in men and 44 days in women) when the 
source of infection was a spouse and lowest (19 days) after a  sex worker contact. 
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The source of C. trachomatis infection was mostly in Finland and only 7% of men and 5% 
of women had contracted their infection abroad (III, Table 5). In half of these men the 
source country was Russia or Estonia and in 30% of these women countries in southern 
Europe.  
 
 
7.3.4 Contraceptive use and partner history 
 
Women with C. trachomatis infection used oral contraceptives (55%) significantly more 
often and condoms (8%) more seldom than women without this infection, 34% and 14% 
respectively (Table 8).    
     
The patients with C. trachomatis infection reported significantly more often a high number 
of sexual partners (>5 partners in 32% of men and 14% of women) during the previous 12 
months than the patients without C. trachomatis infection (>5 partners in 18% of men and 
14% of women; Table 8). They had also more often a past history of C.  trachomatis 
infection (10% in men and 11% in women).   
 
 
7.4 C. trachomatis infection in Finland in 1995-2000 (IV) 
 
A total of 61 845 cases (in the age group 10-69 years) with C. trachomatis infection, 62% of 
them women, were reported to the NIDR by the laboratories in Finland in 1995-2000 . 
During this period the incidence of C. trachomatis infection increased from 23.4 /10 000 in 
1995 to 29.2/10 000 in 2000. A similar trend was seen in the other Nordic countries (IV, Fig 
1). The increase was evident both in women and men and during the six-year period the 
increase was 1.22-fold in women and 1.31-fold in men (IV, Fig 2). 
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7.4.1 Incidence by gender in different age groups 
 
In 1995, 30% of the female cases with C. trachomatis infection were under the age of 20 
years and in 2000 the percentage was as high as 33.5% (Fig. 4, IV Fig.3). In men, these 
percentages were lower, i.e. 10.9% and 13.3%, respectively. When the incidence was 
analyzed according to the 10-year age groups, an increase was most evident in the age 
groups 10-19 and 20-29 years for both men and women (IV, Fig. 3). In women, the increase 
in incidence was 1.37-fold in the age group 10-19 years and 1.24-fold in the age group 20-29 
years. In men, the increases in incidence were 1.69- and 1.40-fold, respectively. 
     
When the incidence rate ratio between women and men in the 10-year age groups were 
analyzed for the whole six-year study period, it was found that the ratio was 5 for women in 
the age group 10-19 years (IV, Fig. 4). In the age group 20-29 years the ratio was still 1.5 for 
women, but in the age group 30-39 years no difference existed between women and men. 
 
 
Figure 4.  The  number of C. trachomatis cases in the age group of 10-25 years by gender in  
2000. 
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7.4.2 Incidence by domicile 
 
The highest age-adjusted C. trachomatis infection incidence was found in urban areas for 
both women and men (IV; Fig.5). During the six-year period the incidence increased from 
35.3 to 41.6/ 10 000 in women and from 20.7 to 25.1/ 10 000 in men. The highest increase 
of C. trachomatis incidence occurred, however, in the non-urban densely-populated areas 
(IV, Fig. 5). In these areas the incidence increased from 19.1 to 29.6/ 10 000 in women and 
from 11.8 to 20.2 / 10 000 in men.  
 
 
7.4.3 Number of annual sex partners and use of contraception 
 
Data from the STD clinics of the SSSN in 1995-2000 disclosed a significant increase in the 
proportion of cases with a high number of annual sex partners in the young women. In the 
age group 10-29 years 8.3% of women with C. trachomatis infection reported five or more 
annual sex partners in 1995, whereas the percentage had increased to 18.8% in 2000. In men 
no similar increase was evident and the percentages were 32.6% and 38.2%, respectively. 
      
Use of oral contraceptives did not change in the age group 10-29 years during the six-year 
study period. In 1995, 60.8% of the women with C. trachomatis infection used oral 
contraceptives and in 2000 the percentage was 57.0%.    
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8 DISCUSSION   
 
8.1 Syphilis in Finland (I)  
 
At present, syphilis notification in Finland is mandatory both for the physicians and 
laboratories and the notifications are linked as cases in the NIDR. The laboratories report 
positive syphilis serology to the NIDR without knowing whether the positive finding is due 
to early infection or only a serologic scar of previously treated syphilis. Unfortunately the 
latter cases, though no detailed information from the physician exists on the case, are at 
present also compiled in the official numbers of annually notified cases of syphilis in 
Finland. This kind of laboratory “over-reporting” gives higher national incidences of 
syphilis than those based only on contagious and treatable cases verified by physicians. Due 
to the possibility of this bias, the outbreak of syphilis in Finland in 1995 was analyzed by 
first confirming all diagnoses of untreated syphilis from the physicians´ notifications or, 
when these were not available, by contacting the respective physician personally.  
 
Endemic syphilis had been eradicated years ago in Finland but in 1995 the incidence of the 
disease doubled. A total of 120 patients were encountered and the cases appeared mostly 
near the eastern border and in the Helsinki metropolitan area from where there is frequent 
travel to and from Russia and Estonia. These countries had experienced huge epidemics of 
syphilis since the early 1990s (Linglöf 1995, Tichonova et al. 1997, Uuskula et al. 1997, 
Pöder and Bingham 1999). The reason for the increased incidence of syphilis in 1995-2000 
in Finland was shown to be import of syphilis mainly from Russia by Finnish men (I, Table 
2). Supporting the importance of close travel connections as a reason for the spread of 
syphilis from Russia to Finland is the fact that somewhat more remote countries like 
Sweden, Norway or Denmark did not experience any marked increase of syphilis in 1995 or 
thereafter (Moi 2001). However, tourism to Russia and Poland has been reported to import 
syphilis westwards as far as the United Kingdom (Higgins et al. 2000, Sherrard et al. 1997). 
The source partners for Finnish men contracting syphilis in Russia were mostly  sex workers 
or other casual partners. We did not, however, find any evidence that mobile sex workers 
had spread syphilis in Finland as recently reported e.g. in Italy (Smacchia et al. 1998). A 
similar imported heterosexual outbreak of syphilis was reported from Vancouver, British 
Columbia with a dense concentration of cases among sex workers and their clients (Patrick 
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et al. 2002). It is of interest that the syphilis epidemic in Finland occurred also almost totally 
in the heterosexual population. Recently, an epidemic of syphilis was noticed among male 
homosexuals in England and Ireland, and many of the cases were co-infected with HIV 
(Lacey et al. 2001, Hopkins et al. 2001). A decreasing trend for safe sex seems to be the 
reason for this and the possibility exists that in the near future syphilis may also spread into 
the homosexuals in Finland.    
     
The majority of syphilis cases in Finland in 1995 and after remained sporadic and consisted 
usually of no more than one or two secondary infected partners. The only exception was a 
local cluster with 18 infected cases encountered in the beginning of the epidemic in the City 
of Tampere in 1995. This cluster was clearly due to low awareness of syphilis among the 
cases and also among health care providers because syphilis had been almost non-existent in 
the city. The eradication of the outbreak took one year and was aided by local educational 
campaigns and successful partner notification by STD experts. It is of interest that a very 
similar rapid outbreak of syphilis with 27 heterosexual patients appeared in Bristol in the 
UK in 1997, but there a few patients were unable to identify most of their casual partners 
and the outbreak continued (Battu et al. 1997).  
     
After notification of the import of syphilis from Russia and a few cases also from Estonia in 
1995 (Hiltunen-Back et al. 1996), information on the risks of unprotected sex in these 
countries and on the symptoms of syphilis was given to health care providers and the public 
especially in the southern part of Finland. Moreover, the special STD surveillance network 
established in 1995 was alarmed and laboratories also started to report cases with positive 
syphilis serology to the NIDR. Trained experts handled partner notification and up to 90% 
of source partners living in Finland were traced and checked. Since 1995, serological 
screening for syphilis was continued effectively in the STD clinics, and among blood donors 
and pregnant women. In the STD clinics and among the blood donors the syphilis yield was 
somewhat lower in 2000 than in 1995, suggesting that the number of asymptomatic 
infections in the main population was decreasing. A slight increase in the number of 
pregnant women with syphilis was observed in the maternity clinics, but this seemed to be 
due to an increase in immigrant pregnant women with syphilis.  
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Although the risk for transmission of syphilis across the border from Russia and Estonia to 
Finland continues to be huge, it is important to note that the incidence of syphilis has 
remained fairly constant and that no endemic clusters have appeared since 1995. It can, 
therefore, be concluded that all the surveillance, notification and screening methods used in 
Finland together with the efforts to educate health care providers and the public aided in the 
control of the syphilis. The syphilis epidemics in Russia and Estonia seem to show some 
signs of decline (Riedner et al. 2000, Uuskula 2001) and, therefore, a decrease in the number 
of cases of imported syphilis can be expected to occur in the near future also in Finland. 
However, the recent huge epidemics of HIV infection among intravenous drug users in 
Russia and Estonia (Stephenson, 2000, Uuskula 2001) constitute an important new threat for 
Finland. 
 
 
8.2 Gonorrhoea in Finland (II)  
 
The prevalence of gonorrhoea decreased among attendees at the two STD clinics in Helsinki 
from 3.3% in 1990 to 0.9% in 1995 (II, Table 1). Moreover, the prevalence of gonorrhoea 
was markedly lower than the prevalence of C. trachomatis infection and in 1990 there were 
three times and in 1995 nine times fewer patients with gonorrhoea than with C. trachomatis 
infection in the STD clinics. The decline of gonorrhoea was nationwide because in the same 
period the incidence in Finland decreased from 47/100 000 to 7/100 000. The data from the 
two STD clinics showed that the rapid fall in the rate of gonorrhoea was entirely due to the 
decrease of endemic cases, a trend that was observed also in Sweden (Fredlund et al.1993). 
In contrast to endemic cases, the rate of imported gonorrhoea remained unchanged although 
travel from Finland to Russia and Estonia increased enormously. In these countries the 
incidence of gonorrhoea was 3-5 times higher in 1990 and 30-40 times higher in 1995 than 
in Finland (Linglöf 1995). However, the annual number of gonorrhoea imported from 
Russia and Estonia remained low, i.e. below 50 cases, during the whole study period. This 
finding from the two STD clinics in Helsinki suggests that imported gonorrhoea had no 
influence on the rapid decline of gonorrhoea in Finland in 1990-1995.  
    
While in gonorrhoea the source was often abroad in 1990-1995, over 90% of the case 
controls with C. trachomatis contracted their infection in Finland. In agreement with high 
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prevalence of endemic C. trachomatis infection, 31% of the patients with endemic 
gonorrhoea had a concomitant C. trachomatis infection. Similarly high concordance rates 
have also been reported in England and the Unites States (Zimmerman et al.1990, Matondo 
et al. 1996, David et al. 1997). Interestingly, the present patients with imported gonorrhoea 
had a significantly lower 14% frequency of concomitant C. trachomatis infection. Most of 
the imported gonorrhoea cases were contracted from Russia and Estonia, suggesting that 
these countries had a rather low prevalence of C. trachomatis infection. However, no data 
based on C. trachomatis screening studies in unselected populations known to suffer from 
epidemics of gonorrhoea and syphilis is available from these countries (Linglöf 1995, 
Uuskula 2001). In Lithuania the prevalence of C. trachomatis infection in women attending 
women´s health care units was 8.4%, but there is no other reliable prevalence data available 
from eastern Europe (Domeika and Hallen 2000, Domeika et al. 2001, Domeika et al. 2002).  
     
In order to learn about the possible reasons for the epidemiological differences in 
gonorrhoea and C. trachomatis infection, the demographic findings and source patient 
profiles were analyzed. The patients with gonorrhoea attending the two STD clinics in 1990-
1995 were more often men than women, they were also older and more often married, and 
less often students than the case controls with C. trachomatis infection. Though the patients 
with gonorrhoea were often married, they had casual source partners more frequently than 
the patients with C. trachomatis infection. One explanation for this and the persistent high 
rate of endemic C. trachomatis infection in Finland could be that C. trachomatis is 
transmitted within the classical core groups of sexually active young people. In contrast to 
this, gonorrhoea seems to be contracted more often due to sexual mixing, e.g. from 
temporarily infected, incidental source partners (Yorke et al. 1978, Potterat et al. 1985, 
Garnett et al. 1993). In contrast to Finland ethnic communities of low socioeconomic class 
are known to have high rates of gonorrhoea in certain cities in England and the United States  
(Potterat et al. 1985, Rice et al. 1991, Lacey et al. 1997).  
     
One reason for the decreased incidence of endemic gonorrhoea in Finland and other western 
European countries could be the change in antibiotic treatment practices. Fluoroquinolones, 
mainly ciprofloxacine, have been used since 1987 in Finland as an oral, single-dose therapy. 
The efficacy of this treatment is well documented and Neisseria gonorrhoeae strains with 
lowered ciprofloxacine sensitivity were very rare in the early 1990s in Finland (Nissinen et 
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al. 1995). A change is now evident and in 1999-2000, 10%-20% of the strains isolated were 
resistant to ciprofloxacine (Huovinen et al. 2002). The decline in the incidence of 
gonorrhoea ceased in Finland in 1995, similarly to the other Nordic countries, and one 
reason for this could be increasing importation of ciprofloxacine-resistant N. gonorrhoea 
strains especially from the Far East (Moi 2001, Berglund et al. 2001).  
 
. 
 8.3 C. trachomatis infection in Finland (III, IV)  
 
In the late 1980s, the incidence of C. trachomatis infection was high but decreasing in 
Finland, Sweden and Norway (Moi 2001). In Finland and Sweden the incidence reached its 
lowest level in 1994, but since then the rates have increased in both countries in parallel (IV, 
Fig.1). The purpose of the sentinel STD surveillance network study in 1995-1997 (III) and 
the NIDR study in 1995-2000 (IV) was to obtain more detailed information on the 
epidemiology of C. trachomatis infection in Finland. 
 
 
8.3.1 Prevalence in the SSSN and endemic source of infection 
 
The prevalence of C. trachomatis infection was high, i.e. 8.4%, among the patients attending 
the STD clinics compared with 5.3% among the patients tested for STIs in the non-STD 
clinics in the SSSN. The prevalence was highest, 16% in women and 14% in men, in the age 
group 15-19 years in the STD clinic population. In 1990-1995 in the two STD clinics in 
Helsinki the prevalence decreased from 10.2% to 8.1%.  
     
In the study in the two STD clinics in Helsinki in 1990-1995 (II), over 90% of C. 
trachomatis infections were found to have an endemic source. The sentinel STD clinic 
survey (III) performed in 1995-1997 confirmed this result. It also showed that only 6% of 
the endemic C. trachomatis infections were contracted from foreigners living in or visiting 
Finland. Therefore, the import of C. trachomatis infection by Finns or foreigners from 
abroad seems to have no major effect on the current C. trachomatis epidemic in Finland.  
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8.3.2 Incidence   
 
Data in the NIDR showed that from 1995 the incidence of C. trachomatis infection 
increased in Finland. The increase was evident both in women and men with C. trachomatis 
infection (IV, Fig. 2). The reliability of the increasing incidence of C. trachomatis infection 
is a matter of discussion. Data in the NIDR is based from 1995 on mandatory laboratory 
notification of C. trachomatis infections. Data from the laboratory based surveillance system 
has been reported to have higher coverage than that from the conventional physician 
notification based system (Effler et al. 1999). In agreement with this, we observed in 1995, 
when the parallel notification from the physicians and laboratories to NIDR was in use, that 
approximately 30% of C. trachomatis cases were not notified by the physicians. The 
effective laboratory notification system is, however, unlikely to be the cause of the observed 
increases because it could have caused a sudden increase in the incidence rates in 1995-
1996, but not continuously increasing incidence rates for the whole six-year study period. 
Moreover, a parallel increase in the incidence of C. trachomatis occurred also in Sweden in 
1995-2000 where surveillance based on the laboratory notifications was started many years 
earlier.  
     
A shift to the use of more sensitive laboratory tests could also have caused increased 
incidence of C. trachomatis in Finland in 1995-2000. Previously, we showed in our STD 
clinic setting that the polymerase and ligase chain reaction test method detected 7% more C. 
trachomatis cases than the standard culture method (Puolakkainen et al.1998). In 1995, only 
21% of the diagnostic tests leading to laboratory notification to the NIDR were based on 
nuclear acid amplification methods in contrast to 95% in 2000. Therefore, part of the 
increase in C. trachomatis incidence rates in 1995-2000 is probably due to the shift to more 
sensitive laboratory tests. If this explanation is valid, the increasing incidence of C. 
trachomatis would be expected to level out in the near future because laboratory testing is 
now almost solely based on these sensitive tests. In 2001, the incidence of C. trachomatis 
infection was 234/100 000 (NPHI 2002), i.e. still increasing, obviously indicating that the 
increase is due to other factors than the frequent use of the sensitive laboratory test methods. 
We do not know, however, whether the total number of C. trachomatis tests performed in 
the laboratories in Finland has changed during recent years. A slight increase in testing has 
occurred in the sentinel STD network clinics due to an increasing number of attendees 
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(Table 6). No national screening programmes for C. trachomatis infection have yet been 
started in Finland and therefore it seems unlikely that the recent increases in the incidence of 
C. trachomatis in Finland are due to any changes in screening or laboratory testing practices.  
 
 
8.3.3 Risk groups and source partners 
 
It is of interest that data analyzed from the NIDR in 1995-2000 showed the highest increase 
of C. trachomatis incidence in the youngest (10-19-year-old) age group for both women and 
men. In this age group the incidence of C. trachomatis was five times higher in women than 
in men. In the age group 20-29 years the incidence increased similarly in women and men, 
and the incidence was 1.5-fold greater for women. Previous studies from genitourinary 
clinics in Britain and from several other countries in Europe have also reported that young 
people, particularly women below 20 years of age, are at highest risk for C. trachomatis 
infection (Egger et al. 1998, Simms et al. 1997, van Duynhoven et al. 1997, Fenton et al. 
2001). As expected the highest C. trachomatis incidence rates in Finland were found in the 
cities and the lowest in rural areas. Interestingly, the increase in the incidence in 1995-2000 
was most evident in densely populated non-urban areas and not in the cities. The reason for 
this seems to be that the population of Finland is becoming increasingly concentrated in the 
southern parts of the country where especially young people are known to move due to their 
studies or work.  
     
In the sentinel STD network survey in 1995-1997, young women using oral contraceptives 
were identified as a group of higher risk for C. trachomatis infection (III, Table 4). 
Previously, Paukku et al. (1997) reported that the prevalence of C. trachomatis was high, i.e. 
5.6%, among women attending family planning clinics in Finland. A recent meta-analysis 
has also shown that the use of oral contraceptives involves an almost twofold risk for C. 
trachomatis infection (Cottingham et al. 1992). In addition, we found that the women with 
C. trachomatis infection reported the use of a condom during the suspected intercourse only 
half as often as the women without C. trachomatis infection. The use of condoms decreased 
in the 1990s in Finland and this contributes to C. trachomatis  transmission (Haavio-
Mannila and Kontula 2001). The use of no precautions against either pregnancy or STIs is 
common and has increased recently (Kontula et al. 2001). We further analyzed whether the 
increase in C. trachomtis incidence in 1995-2000 might parallel increasing risk-taking 
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behaviour among adolescents and young adults. In women, but not in men, a significant 
increase occurred in the proportion of cases reporting five or more annual sex partners and 
the percentage doubled from 8% in 1995 to 19% in 2000. During the same time the use of 
oral contraceptives remained at a constant level. Supporting an educational background for 
this risk taking behaviour, a recent study among adolescents in Finnish schools showed that 
since the early 1990s knowledge of the asymptomatic nature and transmission of STIs has 
decreased (Liinamo et al. 2000, Kontula et al. 2001). Recently, James et al. (1999) found 
that among teenagers in England young age was significantly associated with delay in 
seeking treatment for C. trachomatis infection. At present in Finland, the time from 
contracting a C. trachomatis infection to diagnosis is rather long, i.e. on average five weeks 
(III, Table 6). Therefore, it seems clear that the delay in diagnosis and treatment favours the 
spread of C. trachomatis infection especially among adolescents and young adults. This 
together with the decrease in the school health and family planning services in Finland in the 
late 1990s has increased the number of abortions and STIs among adolescents.   
        
A detailed analysis was performed on the source partners of patients with C. trachomatis 
infection. In 61% of the men and 46% of the women the C. trachomatis infection was 
contracted from a casual source partner (III, Table 5). Only 2% of the men contracted C. 
trachomatis from a sex worker showing that sex workers are not as important a source of C. 
trachomatis infection among Finnish men as they are e.g. in the Netherlands (van de Laar et 
al. 1997). A high number of casual partners is a well-known risk factor for various STIs 
(Vuylsteke et al. 1999). In agreement with this, we found that 32% of the men and 14% of 
the women with C. trachomatis reported a history of five or more partners during the 
preceding 12 months. Similarly, as many as 10-11% of the men and women with C. 
trachomatis had been treated for C.trachomatis infection during the preceding 12 months. In 
the late 1990s, every fourth Finnish and Swedish women in the age group 18-54 years have 
had at least ten sexual partners (Haavio-Mannila and Kontula, 2001). According to Haavio-
Mannila and Kontula (2001), 12% of young men and women have had a C. trachomatis 
infection. 
 
These findings show that young people having frequent sex partners and a history of 
previous C. trachomatis infection are a special target group for educational counselling on 
safe sex. The present results also showed that as many as 37% of the men and 61% of the 
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women contracted C. trachomatis from their regular partners (III, Table 5). The spread of C. 
trachomatis infection to regular partners is not unexpected because the symptoms are often 
mild or even absent for a long period of time (Mc Cormack et al. 1979, Cates et al. 1991). In 
the present study the median time from the exposure to the diagnosis of C. trachomatis 
infection in the STD clinic was 34 days and about the same in both men and women. The 
long time lapse between exposure and diagnosis favours the spread of C. trachomatis 
infection. In agreement with this, as many as one third of the present patients with C. 
trachomatis infection reported sex with a second partner before they attended the STD clinic 
and became aware of their C. trachomatis infection. This shows that effective partner 
notification is still important in combating the epidemics of C. trachomatis infection.   
 
 
 
 
8.4 General aspects 
 
STIs are among the commonest causes of illness in the world and have far reaching health, 
social and economic consequences. National and global epidemiological data on various 
STIs are therefore collected continuously for surveillance purposes. Incidence data from 
different areas reveal outbreaks of STIs such as the outbreak of syphilis in countries of the 
former Soviet Union (Tichonova et al. 1997) and the spread of HIV infection e.g. in eastern 
Europe (Dehne et al. 1999). Finland and the other Nordic countries have a long history of 
national notification for syphilis, chanroids and gonorrhoea (Moi 2001). From 1987 it has 
also been mandatory for physicians to report sexually transmitted C. trachomatis infection. 
These national notification systems provide important epidemiological data for the health 
authorities in the respective countries (Desenclos et al. 1993). For example, in the early 
1990s in Finland and Sweden they documented a continuous decrease in the incidence of C. 
trachomatis infection, but in 1995 a parallel increase in the incidence started in both 
countries. Previously, surveillance of syphilis, chanroids, gonorrhoea and C. trachomatis 
infections in Finland was based only on physicians´ notifications, but from 1995, mandatory 
reporting covered also all microbiological laboratories. In the present study the notifications 
of C. trachomatis infection from both these sources to the NIDR in 1995 were analyzed and 
underreporting by the physicians was revealed. This was not unexpected because about 
10 000 C. trachomatis infections are diagnosed annually and filling in the notification forms 
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means an extra workload for several hundred physicians. On the other hand, the same 
workload is spread over only 50 laboratories which today send over 70% of the C. 
trachomatis notifications to the NIDR electronically (NPHI 2001). This kind of laboratory 
reporting system has recently been examined in the United States and shown to be more 
effective than the conventional system based on mailed notification forms (Effler et al. 
1999). Due to the obvious advantages of the laboratory-based reporting of C. trachomatis 
infection, notification of this STI by physicians was stopped in Finland in 1998.  
    
For an epidemiological point of view the reporting of C. trachomatis infections solely by 
laboratories has some disadvantages when compared to notification by physicians. Firstly, 
the data sent by the laboratories includes information on the place where the test was 
sampled but no data on the place where the infection was contracted either in Finland or 
abroad. The laboratory notification also lacks information on whether the partners can be 
traced for examination and treatment. An obvious need in the future is also to get the 
laboratories to report the total number of tests performed annually for C. trachomatis 
infection. It is also important to get the information on the temporary screening programs in 
order to exclude these findings from routine notification data.  All this information would 
allow the calculation of prevalence figures for positive findings, making it possible to follow 
whether important changes occur in overall testing activity within gender or certain age 
groups. This kind of analysis might also give an explanation of why at present, about 60% of 
all notified C. trachomatis cases are in women both in Finland and in Sweden. It seems 
rather obvious that due to the well-known risks for reproductive health women are more 
readily screened than men. Women also use the reproductive health services more than men. 
It is also possible that for the same reason male partners of the infected women are treated 
quite often without any laboratory testing and due to this no notification is sent to the NIDR. 
If the explanation that men are at present “undertested” for C. trachomatis infection in 
Finland is valid, the consequences would be epidemiologically harmful. In agreement with 
this view, a study from the United States highlighted the impact of men as a significant 
reservoir of infection and recommended more attention to be paid to the infected males and 
their education on safe sex (Michelson et al. 1999).  
 
The sentinel STD surveillance network was established in 1995 in order to collect more 
detailed epidemiological data on the STIs than that available from the NIDR. Moreover, 
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STD clinics register also patients with genital herpes simplex and human papillomavirus 
infections which are not generally notifiable infections in Finland. Importantly, data is also 
collected from those attendees who do not have any STIs in order to get comparison data on 
possible source partners and risk-taking behaviour. A rather similar sentinel network has 
been previously described in Italy, but it does not collect data from the non-infected patients 
(Giuliani et al. 1998). The Finnish SSSN was started especially to get more detailed 
information on the epidemiology of C. trachomatis infection. At the end of the study period 
in the year 2000 the network reported 2 203 patients with C. trachomatis infection, i.e. 19% 
of all the cases notified in Finland. The SSSN data provides continuously important 
additional information on C. trachomatis and other STIs and forms therefore a good 
epidemiological tool to supplement the notification data collected in the NIDR. The latter 
documented a significant and continuous increase in the incidence of C. trachomatis in the 
young age groups in 1995-2000 and the data from the SSSN revealed that at the same time 
the percentage of women reporting five or more annual partners increased significantly. The 
SSSN data also confirmed that 90% of C. trachomatis infections are endemic and showed 
that men contract this infection mostly from casual partners and women from regular 
partners. This gender difference in source partners should be examined in more detail by 
further studies to identify possible sexual network patterns which could be targeted in 
prevention programmes (Potterat et al. 2002). The SSSN data showed also that the median 
time from contracting C. trachomatis infection to diagnosis is 5 weeks and that 30% of the 
patients reported having had sex with a new partner during this period. This information is 
important and shows that all possible efforts should be made to shorten the time for 
transmission. 
 
The spread of STIs typically depends on relatively long periods of infectiousness as an 
asymptomatic carrier and on high transmissibility per sexual contact. Mathematical models 
help to analyze STI epidemiology and recently Anderson & Garnett presented a simple 
formulation for this purpose in homogeneously mixing population (Anderson and Garnett 
2000). The basic reproductive number (Ro) is defined as the average number of secondary 
infections generated by one infectious individual in an entirely susceptible population and its 
magnitude determines the likelihood, speed  and scale of spread of STI. To obtain this index 
(Ro=βcD), one needs to know the transmission probability per partnership (β), the average 
rate of sexual partner change (c) and the mean duration of infectiveness (D). The last two 
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indexes can be obtained for C. trachomatis infection, e.g. by age and gender from the SSSN 
data and this information could then be used in future to analyze possible changes in 
reproductive numbers in a given subgroup targeted, e.g. by specific screening or educational 
interventions.   
 
Interventions for control of the present C. trachomatis epidemics in Finland could include 
special educational campaigns and a system could be tried where partner samples are mailed 
directly from home to the laboratory (Andersen et al. 1998). The effects of such 
interventions could be quite easily documented in the SSSN by performing the intervention 
in the service area of one network clinic and leaving another similar clinic as a control. The 
SSSN could be also a good tool to sample any additional detailed information from the 
attendees, e.g. on condom use. Studies examining the reasons for risk-taking behaviour in 
adolescents and especially why women using contraceptives seem more prone to neglect the 
use of condoms with casual partners are needed before starting educational programmes. 
The present SSSN data identified also a group of men and women who had a history of one 
or several previous C. trachomatis infections. A special task would be to examine this 
important subgroup in more detail in order to learn what possibilities exist to educate these 
people in safer sex practices. According to a recent study among adolescents in Finnish 
schools, knowledge about STIs and their asymptomatic nature decreased in the 1990s 
(Liinamo et al. 2000, Kontula et al. 2001). Abortions, teenage pregnancies and STIs are 
increasing among adolescents in Finland (Kontula 2001). Sex education programmes among 
SSSN attendees should be considered with the knowledge that even intervention with a 
specially designed sex education programme delivered by teachers failed to reduce sexual 
risk taking among British adolescents (Wight et al. 2002).  
 
National surveillance systems are important in detecting STI outbreaks. A syphilis outbreak 
occurred in Finland in 1995 caused mainly by import from Russia and the Baltic countries, 
and this infection now seems fairly well controlled in Finland. An increase in notified 
syphilis occurred also in Norway, Sweden and Britain in the late 1990s (Moi 2001, Doherty 
et al. 2002). In contrast to Finland, several endemic foci have been encountered in England 
where syphilis seems to be spreading mainly among homosexuals (Doherty et al. 2002). 
This kind of transmission could also be a problem in future in Finland. The incidence of 
gonorrhoea remained low in the late 1990s in Finland. About 50% of the cases are imported 
  61 
and an important new problem is the increased resistance to ciprofloxacine found especially 
among the imported strains both in Finland and Sweden (Huovinen et al. 2002, Berglund et 
al. 2002). Where these resistant strains are not controlled by special efforts one can expect 
endemic foci and an increasing incidence of gonorrhoea.  
 
In contrast to syphilis and gonorrhoea, the incidence of C. trachomatis infection is at present 
continuously increasing in Finland despite sensitive diagnostic methods and the availablity 
of effective single-dose treatment for everyone through the public health care system. A 
national strategy for the prevention of C. trachomatis infection is urgently needed in 
Finland. It should include screening and educational programmes targeted at special risk 
groups identified from the surveillance data in the NIDR and SSSN. These two surveillance 
systems also form an excellent tool for monitoring the effects of preventive measures.  
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